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Abstract 
Despite significant advances in drug discovery and vaccination strategies 
during the last decades, infectious diseases are still a major health problem 
worldwide. Among these, infections by mycobacteria are particularly deadly, and 
Mycobacterium tuberculosis alone – the causative agent of tuberculosis – is 
estimated to infect a third of the world population and is responsible for 9 million new 
cases and 1.5 million deaths every year. Interestingly, most people do not develop 
active disease following infection, but instead are capable of controlling infection and 
remain in an asymptomatic state termed latent infection. Although how the immune 
system controls infection is unclear, it is clear that T cells are a key component of a 
successful response against mycobacteria, since infection with human 
immunodeficiency virus (HIV) greatly increases susceptibility to infection. Because T 
cells play such an important role in controlling mycobacterial infections, there is 
considerable interest in understanding which subsets are necessary for protection, 
which mechanisms are employed by these cells to limit bacterial growth, and whether 
such cells can be elicited by vaccination strategies. To clarify the role of T cells 
during immunity to tuberculosis, we addressed two aspects of T cell biology: how 
infection impacts the thymus, the organ where T cells differentiate; and how CD8+ T 
cells mediate protection during tuberculosis. 
Our lab had previously shown that mycobacteria could disseminate to the 
thymus and interfere with thymic function. However, it was unclear whether the 
immune system could control thymic infection and halt bacterial growth in this organ. 
Here we show that an immune response is recruited to the infected thymus and 
controls infection. This response involves the production of pro-inflammatory 
cytokines by antigen-specific CD4+ and CD8+ T cells, which stimulate infected cells 
and leads to control of bacterial replication. Interestingly, these T cells are not cells 
undergoing differentiation in the thymus, but rather are activated cells that recirculate 
from infected peripheral organs to the thymus to fight infection. This recruitment is 
associated with the production of the chemokines CXCL9 and CXCL10 in the 
infected thymus, and recirculating antigen-specific T cells that express CXCR3 and 
preferentially traffic to the thymus. 
In a second set of studies, we investigate how CD8+ T cells contribute to 
immunity against M. tuberculosis infection. Although CD8+ T cells are essential for 
optimal immunity during tuberculosis, how they exert protection is unclear. Here we 
describe the generation of a new mouse model, the first carrying T cells expressing a 
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recombinant T cell receptor (TCR) specific for a M. tuberculosis antigen recognized 
by CD8+ T cells – TB10. By combining single cell sorting of antigen-specific cells with 
PCR amplification of their TCRs, we selected 4 TCR candidates specific for TB10. 
These TCRs were cloned into retroviral vectors and used in retrovirus-mediated stem 
cell gene transfer to generate retrogenic mice. These mice express CD8+ T cells that 
recognize and respond to their cognate peptide. More importantly, adoptive transfer 
of retrogenic cells provides protection against aerosol infection with M. tuberculosis. 
We then use these mice to investigate the mechanism by which CD8+ T cells 
mediate protection. By using retrogenic mice that are deficient in the production of 
interferon-γ or perforin, we show that protection mediated by CD8+ T cells requires 
cytokine production but is independent of their cytotoxic capacity.   
Collectively, the studies presented in this thesis clarify different aspects of T 
cell-mediated immunity to mycobacteria; they reinforce that the thymus is not an 
immune privileged organ and should be studied in the context of infection, and 
strengthen the notion that CD8+ T cells are protective after M. tuberculosis infection.  
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Resumo 
Nas últimas décadas observamos incríveis avanços tanto no 
desenvolvimento de vacinas como de antibióticos. No entanto, as doenças 
infecciosas continuam a ser um problema de saúde global. Entre estas, as infecções 
por micobactérias são particularmente mortiferas, e é estimado que um terço da 
população mundial esteja infectada com Mycobacterium tuberculosis – a bacteria 
responsável pela tuberculose. Esta doença causa 9 milhões de novos casos todos 
os anos, resultando em cerca de 1.5 milhões de mortes anuais. No entanto, a 
maioria dos indivíduos infectados não desenvolve a doença, e permanence num 
estadio clinico assimptomatico designado por infecção latente. Apesar de ainda não 
ser claro como é que o sistema imunitário controla estas infecções, as células T são 
um componente essencial neste processo, já que infecção com o virus de 
imunodeficiencia humana (VIH) aumenta significativamente a susceptibilidade à 
infecção com micobactérias. Devido à importância das células T nestes casos, é 
importante clarificar que subconjuntos destas células são necessários para controlar 
a infecção, como é que essas células são protectoras, e se é possível gerá-las por 
intermédio de vacinas. Para melhor entender qual o papel das células T durante 
infecções por micobactérias, focamo-nos em dois pontos: qual o impacto destas 
infecções no timo, o orgão em que as células T se diferienciam; e qual o papel das 
células T CD8+ durante a tuberculose. 
Quando iniciamos estes estudos, era sabido que micobactérias são capazes 
de disseminar para o timo e interferir com a função deste orgão. No entanto não era 
claro se o timo consegue controlar estas infecções, e como o faz. Nos estudos aqui 
apresentados demonstramos que o timo controla a infecção, num processo 
dependente do recrutamento de uma resposta imunitária adquirida para este orgão. 
Esta resposta envolve a produção de citocinas pró-inflamatórias por parte de células 
T, tanto CD4+ como CD8+. Estas citocinas activam as células infectadas, resultando 
no controlo do crescimento bacteriano no timo. Apesar do timo ser o orgão em que 
as células T se diferenciam, os nossos estudos revelam que as células responsáveis 
pelo controlo bacteriano neste orgão não são células que se encontram neste orgão 
no processo de diferenciação, mas antes células T activadas que recirculam dos 
orgãos periféricos para o timo para controlar a infecção. Este processo depende da 
produção das quimoquinas CXCL9 e CXCL10 no timo infectado, e da expressão do 
receptor CXCR3 por parte das células que recirculam. 
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Num conjunto de estudos diferentes debruçamo-nos sobre a contribuição das 
células T CD8+ durante a tuberculose. Apesar de ser aceite que estas células são 
importantes durante a infecção com M. tuberculosis, o mecanismo pelo qual elas 
protegem indivíduos infectados é ainda desconhecido. Para investigar esta questão 
criamos um novo modelo animal, o primeiro ratinho que expressa células T CD8+ 
específicas para um antigénio de M. tuberculosis, o antigénio TB10. Para tal, células 
específicas para TB10 foram isoladas individualmente por citometria de fluxo, os 
seus receptores de células T (TCR) amplificados por reacção em cadeia de 
polimerase (PCR) e sequenciados. Das sequências detectadas, 4 foram 
seleccionadas e clonadas em vectores retrovirais, que foram depois usados para 
gerar animais retrogénicos, via transferência adoptiva de células estaminais 
infectadas com os retrovirus. Estes animais expressam células T CD8+ que 
reconhecem o antigénio de interesse, e transferência adoptiva de células 
retrogénicas é suficiente para proteger significativamente animais de infecção 
aerogénica com M. tuberculosis. Para investigar qual o mecanismo responsável pela 
protecção observada, geramos animais retrogénicos incapazes de produzir 
interferão-γ ou perforina, e demonstramos que as células T CD8+ precisam de 
produzir citocinas, mas não de ser citotóxicas, para proteger animais contra infecção 
por tuberculose. 
Em conjunto os estudos apresentados nesta tese clarificam diferentes 
aspectos acerca da imunidade mediada por células T durante infecções com 
micobactérias: re-enforçam a ideia de que o timo não é um orgão imuno-priveligiado 
e deve ser estudado  no contexto de doenças infecciosas; e que as células T CD8+ 
são protectoras no contexto de tuberculose.      
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Introductory note 
The work reported in this dissertation focus on two distinct, yet related 
projects, which I will try to present in an organized fashion. I will start with a brief 
introduction on the functions of the immune system, the role of the thymus and T 
cells in immunity, and how these participate in the overall immune response to 
tuberculosis. This will be chapter 1. After this, the thesis will be divided on 2 main 
sections.  
The first section compiles a set of studies that focus on the consequences of 
thymic infection by mycobacteria and its impact on ongoing immune responses. 
Historically, this was the original focus of my studies when I started my PhD in Braga, 
Portugal, and a big part of my initial studies after I moved to Boston. This section 
starts with a review (currently under revision) about the problem of thymic infection 
(chapter 2), followed by a manuscripts published in The Journal of Immunology in 
which I am a co-first author (chapter 3). This is a report entitled “T cells home to the 
thymus and control infection”, where we show that T cells re-circulate from the 
periphery to the thymus to control mycobacterial infection.  
The second section focus on the role of CD8+ T cells during Mycobacterium 
tuberculosis infection and our efforts to develop an animal model to improve our 
understanding of what constitutes protective immunity to tuberculosis. This has been 
the subject of my work for most of the time since I moved to Boston. This section 
starts with a brief review on the role of CD8+ T cells during M. tuberculosis infection 
(chapter 4). This introduction serves as the rationale to the development of a new 
animal model to study CD8+ T cell responses following M. tuberculosis infection. In 
chapter 5 we describe the use of retrogenic technology to generate a new mouse 
model expressing a large frequency of T cells specific for the immunodominant TB10 
antigen. This chapter also includes the data generated so far by using this new 
mouse model, presenting how we used retrogenic mice to study CD8+ T cell priming 
following infection and the mechanisms responsible for CD8+ T cell protection during 
tuberculosis.  
Finally, chapter 6 includes a general discussion that focus on the causes and 
consequences of thymic infection, particularly in settings of chronic infection; on the  
role of CD8+ T cells in the mouse model of tuberculosis and how retrogenic mice can 
be used in this context; and on the relationship between the two projects, with an 
overall model on the role of T cells during tuberculosis, both in the thymus and the 
periphery.  
T	  cell	  immunity	  to	  mycobacteria	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Chapter 1 
Introduction
T cell immunity to tuberculosis: the role of the thymus in T cell generation and how T 
cells contribute to host defense against tuberculosis
This thesis revolves around the study of immunity to tuberculosis, 
the disease caused by infection with the pathogen Mycobacterium 
tuberculosis. Because these studies relate to different aspects of 
immunity, I decided to divide them into two sections. The first 
focuses on the role of the thymus during mycobacterial infection; 
the second on the study of CD8+ T cell responses during 
tuberculosis. The current literature related to each topic is 
reviewed at the start of each section. In this chapter, I will try to 
summarize the state-of-the-art of what is common between both 
projects, focusing on how T cells are generated and how they 
participate in the immune response against mycobacteria

Introduction 
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Introduction 
 
immunity (noun): the quality or state of being immune; especially: a condition of being able 
to resist a particular disease especially through preventing development of a pathogenic 
microorganism or by counteracting the effects of its products (Merriam-Webster dictionary). 
 
We live surrounded by microorganisms, yet do not get sick from them all the 
time. This is because, over a period of several hundred million years, multicellular 
organisms have developed a dedicated system to prevent, detect and fight infection1. 
This immune system consists of multiple strategies to protect the body from 
infectious agents and their consequences, and involves several effector cell types 
and different immune molecules. These strategies are commonly divided in two 
major branches, referred to as innate versus adaptive immunity. The major 
differences between these two systems are kinetics, specificity and the ability to 
generate immunological memory2.  
Innate immunity usually refers to components that mount a fast response 
against infectious agents in a non-specific way, creating a front line of defense 
against pathogens. These responses are usually dependent on the recognition of 
general features of infectious agents, by detection of either pathogen or danger 
associated molecular patterns (PAMPs or DAMPs) by specific receptors on immune 
cells – toll-like receptors (TLRs) or pattern recognition receptors (PRRs)3,4. Because 
the innate immune system recognizes general features of microbes, it is not capable 
of immunological memory, i.e., the innate immune response to a subsequent 
challenge with the same pathogen is usually not faster or stronger than the first 
encounter. Important components of innate immunity are dendritic cells, monocytes 
and macrophages, granulocytes (neutrophils, basophils, eosinophils and mast cells), 
the complement system, and natural killer (NK) cells. 
In contrast, adaptive immunity comprises a specialized set of cells with the 
capacity to individually recognize each invading pathogen and mount specific 
immune responses. The major constituents of adaptive immune responses are B and 
T cells. B cells are responsible for antibody mediated immune responses (or humoral 
immunity), and T cells for cell mediated immunity. These cells are characterized by 
the surface expression of specific receptors that are the result of random gene 
rearrangements, therefore yielding virtually endless combinations that are capable of 
Introduction 
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detecting essentially every antigen present in bacteria, fungi, virus and parasites. 
This specificity allows the adaptive immune system to respond faster and stronger to 
a secondary challenge with the same pathogen, a feature described as 
immunological memory2.  
Despite the division of immune responses in these two branches of innate 
and adaptive immunity, successful clearance of infectious agents requires a 
balanced interplay of several components of the immune system. 
 
T cells and the thymus  
 One of the key components of the adaptive immune system are T cells, which 
are defined by the surface expression of the T cell receptor (TCR). There are several 
T cell subsets, whose TCR recognizes different molecules. Conventional T cells 
recognize small peptide fragments bound to major histocompatibility complex (MHC) 
molecules expressed on the cell surface5. NKT cells recognize lipid antigens in the 
context of CD1 molecules. For other subsets, such as γδ T cells and MAIT cells, it is 
still unclear what molecules they recognize. Nonetheless, each T cell expresses a 
TCR, a heterodimer consisting of a pairing of an alpha (α) chain with a beta (β) chain 
– in the case of αβ T cells – or a gamma (γ) chain with a delta (δ) chain – in the case 
of γδ T cells (for simplicity reasons we will focus on conventional T cells in this 
introduction, as they are the main scope of this thesis). 
The T in T cells stands for Thymus, the organ where these cells differentiate. 
T cell precursors are generated in the bone marrow and become functional after 
differentiation within the thymus. The deceptively simple anatomical structure of the 
thymus belies its sophisticated ability to generate self-restricted and mostly self-
tolerant naïve T cells expressing a broad TCR repertoire capable of recognizing 
virtually any foreign antigen (and some self antigens). This complex task is achieved 
by a process that involves somatic recombination of TCR gene segments to generate 
diversity coupled with a succession of interactions between differentiating 
thymocytes and resident cell populations that mediate positive and negative selection 
(reviewed in extensive detail in Starr et al.6). Briefly, when common lymphoid 
progenitors (CLPs) arrive in the thymus from the bone marrow, they are called 
double negative (DN) T cell precursors, due to the absence of the CD4 and the CD8 
co-receptors at the surface of these cells7. Upon entering the thymus, T cell 
precursors start to express recombination-activating gene 1 (Rag-1) and Rag-2 
Introduction 
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genes, which are essential for TCR rearrangement8. Cells that successfully 
rearrange and express a TCRβ chain and pair it with the pre TCRα (pTα) at the cell 
surface pass beta-selection9. After this stage, these cells proliferate rapidly, 
rearrange the TCRα chain, and start expressing both CD4 and CD8 co-receptors, 
earning the designation of double positive (DP) cells7. DP cells can now undergo 
selection, in a process that preserves naïve T cells that can recognize peptides 
presented by MHC (self-restricted) and eliminates most T cells that recognize self-
peptides (self-reactive). Selection is dependent on the affinity of the interaction 
between the TCR expressed by the T cell with the self-peptide-MHC complexes 
expressed at the surface of thymic resident cells. In this way, DP thymocytes 
expressing TCRs that are capable of recognizing these complexes with sufficient 
affinity/avidity receive a positive surviving signal, while cells whose TCR is incapable 
of such recognition die by neglect – this is called positive selection, and ensures that 
T cells are self-restricted10. Upon positive selection, developing thymocytes undergo 
yet another selection event. In this step, thymocytes carrying a TCR with high 
affinity/avidity to the self-peptide-MHC complexes are instructed to die by apoptosis – 
this is called negative selection, and ensures that most self-reactive T cells do not 
leave the thymus, preventing autoimmune responses in the peripheral tissues11. Of 
note, some self-reactive T cells escape thymic selection and make it to the periphery, 
while other cells with high affinity/avidity to self-peptides develop into regulatory T 
cells (Treg)12. It is also during thymic selection that DP cells become either CD4 or 
CD8 single positive (SP) thymocytes. This is determined by what MHC molecules 
their TCR recognizes, and CD4+ T cells are restricted to class II MHC (MHC-II) while 
CD8+ T cells are restricted to class I MHC (MHC-I)6. After thymic selection, naïve T 
cells exit the thymus and migrate to peripheral lymphoid tissues, where they reside 
until they become activated and participate in immune responses (Figure 1).  
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 Figure 1. T cell selection in the thymus. T cell precursors enter the thymus, where 
they undergo a series of events before differentiating into naïve CD4+ or CD8+ T cells. Such 
events include both positive and negative selection, ensuring that T cells are self-restricted, 
and for the most part, self-tolerant. DN – double negative; DP – double positive; MHC – major 
histocompatibility complex; cTEC – cortical thymic epithelial cell; mTEC – medullary thymic 
epithelial cell. 
 
CD4+ and CD8+ T cells 
Despite all the similarities in their development, CD4+ and CD8+ T cells are 
thought to play different roles in immunity. CD4+ T cells, or helper T cells (Th), 
recognize peptides presented by MHC-II, which is only expressed in antigen 
presenting cells (APC). These peptides are usually derived from within vesicles 
resulting from the phagocytosis of infectious agents, and therefore CD4+ T cell 
responses are characterized by the production of cytokines that act on the presenting 
cell as well as the neighboring cells – hence the term helper cell. Interestingly, naïve 
CD4+ T cells (Th0) differentiate into very different subsets depending on the context 
of the activation and the transcription factors they up-regulate (reviewed by Zhou et 
al.13). Briefly, Th1 development is regulated by interleukin-12 (IL-12) and the Th1-
specific T box transcription factor (T-bet). These cells are characterized by the 
Introduction 
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production of interferon-γ (IFNγ) and promote protective immunity against intracellular 
pathogens. Th2 cells promote humoral immunity and are involved in responses 
against extracellular parasites. They are also important in the context of allergic 
reactions and asthma. Their development is regulated by the transcription factor 
GATA-3, and they produce cytokines such as IL-4, IL-5 and IL-13. Th17 cells produce 
IL-17, and are important in the response against extracellular bacteria and fungi. 
Their inflammatory capacity can also promote autoimmunity. Treg are 
immunosuppressive cells that express the forkhead box P3 (FoxP3) transcription 
factor and produce IL-10 and transforming growth factor β (TGF-β). Finally, follicular 
helper T cells (TFH) promote germinal center responses through secretion of IL-21 
and their development is dependent on the B-cell lymphoma 6 (Bcl-6) transcription 
factor (Figure 2).  
 
Figure 2. CD4+ T cell subsets. Naïve CD4+ T cells differentiate into several distinct 
subsets that modulate different functions during immune responses. Differentiation of each 
subset is associated with the specific transcription factor indicated in the figure and each 
population is characterized by the production of the indicated signature cytokines.  
 On the other hand, CD8+ T cells, also called cytotoxic T cells (CTL or Tc), 
recognize peptides presented by MHC-I, which is expressed by almost every 
nucleated cell in the organism. These peptides are usually from cytoplasmic origin, 
and therefore CD8+ T cell responses are important in the fight against viruses, 
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tumors and intracellular pathogens. CD8+ T cells can directly kill the target cell, and 
CTL activity involves the secretion of cytotoxic granules, such as granzymes and 
perforin (and granulysin in humans). In addition to cytotoxicity, cytokine production by 
CD8+ T cells, such as IFNγ and tumor necrosis factor (TNF), also contributes to host 
defense14.  
 Despite the differences between CD4+ T cells and CD8+ T cells, in terms of 
both the cells they recognize and their effector mechanisms, these two subsets 
collaborate in response to immunological challenge and their interaction is key to 
control infection. 
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Tuberculosis 
tuberculosis (noun): a usually chronic highly variable disease that is caused by a bacterium 
of the genus Mycobacterium (M. tuberculosis) and rarely in the United States by a related 
mycobacterium (M. bovis), is usually communicated by inhalation of the airborne causative 
agent, affects especially the lungs but may spread to other areas (as the kidney or spinal 
column) from local lesions or by way of the lymph or blood vessels, and is characterized by 
fever, cough, difficulty in breathing, inflammatory infiltrations, formation of tubercles, 
caseation, pleural effusion, and fibrosis – called also TB (Merriam-Webster dictionary). 
  
 One of the central purposes of the immune system is to protect the body from 
infectious agents, in what can be seen as a battle between immune cells and the 
invading pathogens. These battles are some times fast and intense, and usually 
result in either death of the host or rapid clearance of the infection – such is the case 
for multiple bacterial and viral acute infections. Other times, the battle is long, and 
does not always lead to sterilization – we call these chronic infections. One such 
example, and arguably one of the most interesting examples of host-pathogen 
interactions is tuberculosis, the disease caused by Mycobacterium tuberculosis. 
 Mycobacterial infections are among the major health threats worldwide, and 
humans all over the world are frequently exposed to bacteria from the 
Mycobacterium genus15. This genus includes not only M. tuberculosis - responsible 
for tuberculosis, the leading cause of death from a curable infectious disease in the 
world – but also several other pathogens such as Mycobacterium bovis, 
Mycobacterium leprae, Mycobacterium ulcerans and Mycobacterium avium15. M. 
tuberculosis alone is thought to infect around one third of the world’s population, and 
causes an estimated 1.7 million deaths every year16. The enormous difference 
between the number of infected people and the amount of annual deaths is 
explained by the observation that the majority of infected individuals do not develop 
active disease but instead keep infection under control in a state termed latent 
infection. In fact, only a small fraction of the infected population, around 5-10%, ever 
display active disease and is able to transmit disease, for reasons still unclear17. 
However, in the last few decades, and despite potentially curative drugs to control 
tuberculosis, mycobacterial infections have gained a renewed significance. This is 
mainly due to two reasons: the spread of human immunodeficiency virus (HIV) 
infection, which significantly increases the progression to active disease18; and the 
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emergence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) 
strains of M. tuberculosis19. 
There is currently only one vaccine available to prevent mycobacterial 
infections, although multiple ventures are currently trying to expand this panel. The 
licensed vaccine is a live attenuated form of M. bovis, M. bovis-bacillus Calmette-
Guérin (BCG) that has been used for over 90 years to prevent tuberculosis. Although 
capable of protecting infants from some severe forms of the disease – such as 
miliary tuberculosis – vaccination with BCG displays highly variable efficiency in 
preventing adults from pulmonary tuberculosis, and the mechanism underlying the 
loss of BCG-induced protection in adults is still not clear20,21. This is an important 
example of the shortcomings of our fundamental knowledge of what constitutes 
protective immunity to tuberculosis. This lack of information hinders our ability to 
prevent, fight and eradicate this disease. 
 
Immune responses to mycobacteria 
We are still a long way from fully understanding the delicate interplay 
between the immune system and mycobacteria, but that is not to stay that significant 
progress has not been made. Over the last decades, several aspects of the immune 
response against mycobacteria have been addressed, mostly focusing on the initial 
recognition of bacterial infection by cellular components of the innate immune system 
and on the role of T cell immunity in controlling the infection. 
M. tuberculosis is a facultative intracellular pathogen, usually transmitted by 
the aerosol route, when an infected individual coughs up droplets containing the 
infectious agent22. Once inhaled by a new host, M. tuberculosis is able to invade host 
cells, and is thought to be initially taken up by alveolar macrophages23. In addition to 
tissue resident macrophages, other phagocytes can harbor M. tuberculosis in the 
lung, such as dendritic cells (DC)24, monocyte-derived macrophages25 and 
neutrophils25,26. In addition, M. tuberculosis can be found within non-phagocytic cells, 
such as epithelial cells27 and adipocytes28. How exactly M. tuberculosis is taken up 
by phagocytes is still unclear, but several receptors have been described to 
participate in this process, such as complement receptors, scavenger receptors and 
C-type lectin receptors17. Interestingly, once taken up by cells, M. tuberculosis is able 
to modulate host immunity, resist killing, and survive and even divide within the 
infected cell. Part of the reason why M. tuberculosis is able to evade host immunity is 
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its production of specific virulence factors that prevent lysosome fusion to the 
phagosome, which allows it to evade lysosomal degradation29-31. Additionally, M. 
tuberculosis is able to escape from the phagosome to the cytosol32. Another way by 
which M. tuberculosis interferes with host immunity is by affecting the cell death 
modality of the infected macrophage (reviewed by Behar et al.33). We and others 
have shown that M. tuberculosis modulates the production of lipid mediators within 
the macrophage, stimulating infected cells to die by necrosis – which promotes 
bacterial spreading to neighboring cells – and inhibiting apoptosis34,35. The inhibition 
of apoptotic cell death of the infected macrophage impacts negatively on the 
outcome of the infection, since we have also demonstrated that apoptosis promotes 
bacterial control, at least partially by the means of efferocytosis36. 
On the other hand, the immune system possesses several ways to stimulate 
the intracellular killing of M. tuberculosis within macrophages, which include the 
production of the cytokines IFNγ and TNF37. Although the exact mechanisms on how 
these molecules lead to control of bacterial replication are still a matter of debate, it is 
clear that an effective immune response to fight M. tuberculosis involves various cell 
types, from both the innate and the adaptive immune system. Among these, T 
lymphocytes, both CD4+ and CD8+ T cells, are crucial for the control of tuberculosis, 
because of their ability to recognize infected macrophages and directly kill bacteria or 
by stimulating the macrophage’s antimicrobial activity37.  
Although the ability of CD4+ T cells to control mycobacterial infections has 
been recognized for a long time, the association of AIDS with mycobacterial 
infections strengthen the clinical importance of these cells38. For example, HIV 
infection has been shown to increase progression from latent to active disease by 5- 
to 10- fold38. Conversely, highly active antiretroviral therapy treatment of HIV patients 
and the concurrent reconstitution of the CD4+ T cell compartment decrease 
tuberculosis susceptibility39. These human observations are paralleled by studies in 
the mouse model of tuberculosis, in which mice genetically lacking T and B cells, 
only T cells, only CD4+ T cells, or wild-type mice depleted of CD4+ T cells are 
extremely susceptible to infection40. 
Within CD4+ T cells, several distinct subsets have been demonstrated to 
participate in the control of M. tuberculosis. The most well characterized example is 
that of Th1 cells, whose development depends on the activation of naïve cells in the 
presence of IL-12 and on the expression of the signature transcription factor T-bet41. 
Th1 cells are classically described as producing IFNγ, and accordingly mice unable to 
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produce IFNγ are extremely susceptible to M. tuberculosis42. The essential role for 
IFNγ in the control of mycobacterial infection is also exemplified in people with 
genetic disorders in the IFNγ pathway, which are extremely susceptible to these 
infections, in a clinical syndrome described as Mendelian susceptibility to 
mycobacterial diseases, or MSMD43. These two observations, that both IFNγ and 
CD4+ T cells are essential to the control of M. tuberculosis, gave rise to the 
assumption that IFNγ production by CD4+ T cells is the protective mechanisms 
underlying M. tuberculosis control. However, IFNγ production does not correlate with 
protection in the context of vaccination43-45, and in the mouse model, CD4+ T cell 
mediated protection can be IFNγ independent46,47. Also, M. tuberculosis modulates 
MHC-II expression on infected cells, possibly hampering bacterial recognition by 
CD4+ T cells48. These data raise the possibility that IFNγ-independent mechanisms 
are responsible for the protection mediated by CD4+ T cells, and that other host cells 
– such as CD8+ T cells, iNKT cells, γδ cells, and other innate cells – might act as the 
source of IFNγ in vivo. 
In addition to Th1 cells, other CD4+ T cell subsets have been studied during M. 
tuberculosis infection. These include Th17 cells, Tregs, and more recently Tfh cells. In 
this setting, it has been shown that IL-17 production by Th17 cells improves the 
recruitment of Th1 cells to the infected lung49, and Tfh cells are important in 
granuloma formation50. In contrast, the presence of Treg delays the arrival of effector 
cells to the lung, delaying the establishment of protective immune responses51. 
Although these subsets have been implicated in the response to M. tuberculosis, 
additional studies are necessary to clarify their role in protective immunity and 
immunopathology, both in animal models and in people. 
Like CD4+ T cells, CD8+ T cells have been shown to participate and 
contribute to immunity against M. tuberculosis, in both people and experimental 
animal models52 (CD8+ T cell responses during M. tuberculosis infection are the 
focus of several studies presented in this thesis, and their contribution to tuberculosis 
immunity is debated in more extensive detail in Part II of this thesis). Briefly, mice 
lacking CD8+ T cells display decreased survival than intact mice40, and IFNγ 
production by CD8+ T cells has been shown to promote survival in the absence of 
CD4+ T cells53. In addition to their ability to produce cytokines, CD8+ T cells have 
been shown to by cytotoxic in both humans and mice54-57. However, like for CD4+ T 
cells, the mechanisms responsible for CD8+ T cell mediated protection in vivo and 
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their suitability as effective vaccine targets still requires clarification and needs further 
investigation. 
 
Figure 3. Immune responses to M. tuberculosis. Immune responses to 
tuberculosis involve, among others, macrophages and T cells. Macrophages are essential for 
bacterial uptake, and present mycobacterial antigens to both CD4+ and CD8+ T cells. 
Activated T cells produce cytokines, such as IFNγ and TNF, which stimulate the anti-
bactericidal mechanisms of macrophages. CD8+ T cells can also be cytotoxic, directly killing 
infected cells.  
Overall, significant improvement has been made in painting the picture of how 
the immune system deals with M. tuberculosis infection, both in terms of the players 
involved in this fight and the strategies employed by the bug to evade host immunity. 
However, significant details still need to be elucidated, the most important probably 
being what correlates with protection against M. tuberculosis, which mechanisms do 
T cells employ to restrict bacterial growth and whether these will be able to promote 
bacterial clearance. The lack of such knowledge hinders a rationale approach to 
vaccine development and is a major hurdle in the global fight against tuberculosis.  
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Scope of the thesis 
 
Although T cells have long been recognized as an indispensable component 
of the immune response to mycobacteria, there are several questions that remain 
unaddressed. These include what is the role for CD8+ T cells during M. tuberculosis 
infection, whether they can be protective following infection, and what is their 
mechanism of protection. Also, despite the key role of the thymus in the generation 
of T cells, and the observation that mycobacteria disseminate to this organ, it is 
unclear how the immune system responds to thymic infection and what are the 
consequences of thymic infection for ongoing immune responses. These are the two 
areas of investigation discussed in this thesis, and we aim to: 
In part I - the problem of thymic infection: 
- clarify how the immune system controls thymic infection, and what 
cells are responsible for bacterial control; 
- investigate the mechanisms by which immune cells are recruited to 
the infected thymus. 
In part II - CD8+ T cell responses to tuberculosis: 
- generate a new mouse model expressing CD8+ T cells specific for 
TB10, an immunodominant M. tuberculosis antigen; 
- investigate the protective capacity of CD8+ T cells during M. 
tuberculosis infection; 
- dissect the mechanism(s) responsible for CD8+ T cell mediated 
protection. 
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Part I 
The problem of thymic infection
how the immune system controls thymic infection, and the consequences of thymic 
infection on T cell differentiation
The first section of this thesis compiles studies on thymic infection 
by mycobacteria. It starts with a review on the problem of thymic 
infection, currently submitted for publication. This is followed by a 
manuscripts published in The Journal of Immunology entitled “T 
cells home to the thymus and control infection”, where we show 
how the thymus is able to control M. avium and M. tuberculosis 
infection. Together, these studies help shape the notion of the 
thymus as a target of infection, and that thymic infection as 
important consequences on ongoing immunity

Chapter 2 
Tolerance has its limits: how the thymus copes with 
infection
A review on the consequences of infection on thymic function
(This manuscript is currently under revision)
For a long time, the thymus was considered an immune privileged 
site, protected from any changes occurring in other organs of the 
body, such as during infectious episodes. However, recent data 
has shown that infection impacts thymic structure and function. 
These modifications occur either through pro-inflammatory 
mediators that accompany systemic infection, or by direct infection 
of the thymus by a variety of pathogens, including bacteria, 
viruses, fungi and parasites. In this chapter, we review how 
infection affects thymic structure and function and discuss the 
consequences of alterations in thymic activity on ongoing 
immunity.
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Abstract 
 
The thymus is required for T cell differentiation, a process that depends on which antigens 
are encountered by thymocytes, the environment surrounding the differentiating cells, and 
the thymic architecture. These features are altered by local infection of the thymus and by 
the inflammatory mediators that accompany systemic infection. Although once believed to 
be an immune privileged site, recent studies show that anti-microbial responses are 
recruited to the thymus. Resolving infection in the thymus is important because chronic 
persistence of microbes impairs the differentiation of pathogen-specific T cells and 
diminishes resistance to infection. Understanding how these mechanisms contributes to 
disease susceptibility, particularly in infants with developing T cell repertoires, requires 
further investigation. 
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Introduction 
 
The appearance of adaptive immunity in jawed vertebrates is considered a major 
evolutionary step, as B and T cells enable the immune system to generate and recall 
pathogen-specific immune responses1. Among lymphocytes, T cells are unique in their 
expression of the T cell receptor (TCR). TCR-mediated recognition of microbial peptides 
bound to major histocompatibility complex (MHC) is the principle way that the immune 
system identifies infected cells. T cell precursors are generated in the bone marrow and 
become functional after differentiation within the thymus1. The deceptively simple anatomical 
structure of the thymus belies its sophisticated ability to generate T cells expressing a broad 
TCR repertoire capable of recognizing virtually any foreign antigen. Importantly, thymic 
selection eliminates most potentially harmful self-reactive T cells. After selection, naïve self-
restricted T cells exit the thymus and traffic to secondary lymphoid organs. 
T cell differentiation depends on the thymic microenvironment and the cytokine milieu 
surrounding the differentiating cells1. This raises the possibility that during infection, changes 
in soluble factors or antigens present within the thymus alters T cell differentiation. Indeed, 
recent reports show that systemic infection has detrimental effects on thymus structure and 
function. Furthermore, certain bacteria, virus, fungi and parasites can directly invade the 
thymus (Table 1). These observations suggest that some pathogens, particularly the ones 
that cause chronic infections, interfere with the generation of immune responses designed to 
fight them by disrupting T cell development and possibly altering central tolerance. 
 
Thymus: myth and reality 
 
Altered thymic function is reported during infection in animal models. However, with 
the exception of studies on human immunodeficiency virus (HIV) infection2, few studies have 
addressed whether infection affects thymic function in people. In part, this is because of 
limited availability of human samples, since the thymus is difficult to biopsy. As important are 
misconceptions that have affected how scientists and physicians look at thymic function. 
Although now largely refuted, these include: (1) the thymus is an immune-privileged site 
protected from infection and immune responses; and (2) thymic function is only important 
during early life and dispensable after puberty.  
The notion that the thymus is immune privileged is inseparable from the concept of 
the blood-thymus barrier, considered for several years responsible for an antigen-free thymic 
microenvironment and no ongoing immune responses3. However, it is now clear that the 
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thymus is both a target of infection and a site to where immune responses are recruited 
(Table 1)4-7.  
While the thymus is essential for the establishment of a diverse T cell repertoire early 
in life, it is widely believed to be unnecessary after puberty. This idea is supported by finding 
that the peripheral T cell pool can be maintained by thymic-independent mechanisms8. Even 
if this were true, it is incredibly shortsighted to ignore the effect of infection on the thymus, as 
children and young adults under the age of 24 make up 44% of the world’s population and 
are particularly vulnerable to infection. In 2011, nearly 6.9 million children under the age of 
five died, with infection causing more than half of these deaths9. Although most of these 
deaths were due to acute infection (pneumonia, 14%; diarrhea, 10%; measles, 1%), a 
significant number were due to chronic infection (malaria, 7%; HIV/AIDS, 2%; tuberculosis, 
1%)9. These numbers increase with age and HIV/AIDS and tuberculosis account for 11% of 
deaths among young adults (10-24 years) worldwide9. Interestingly, both HIV and 
Mycobacterium tuberculosis infect the thymus and cause alterations in T cell output, which 
could be relevant both in settings of vaccination and during natural immunity to these 
pathogens2,10,11.  
Although childhood infections are arguably a greater cause of morbidity and mortality 
than adult infection, particularly in the developing world, recent studies reinforce the idea 
that the thymus affects resistance to infection during adulthood. Reduced thymic output of T 
cells is associated with HIV progression to AIDS and the thymus has been implicated in the 
successful immune reconstitution of AIDS patients in response to antiretroviral therapy2. 
Moreover, thymectomy during early childhood has been linked to accelerated decline in 
immunologic function, particularly following cytomegalovirus (CMV) infection12, and work on 
experimental viral infection models finds that continuous recruitment of naïve T cells from 
the thymus has a beneficial role in the control of persistent infections13-15. The integrity of the 
adult thymus is also required for other aspects of ongoing immunity including antibody 
generation16 and oral tolerance17. These observations indicate that an intact and functional 
thymus is required for optimal immunity to infection throughout life. 
 
How does infection alter thymic function? 
 
There are two ways in which infection can affect the thymus: local versus systemic. 
Local refers to effects of direct infection of the thymus by microbes. Systemic refers to the 
consequences of infection somewhere else on the thymus. Systemic effects occur when 
soluble factors, such as glucocorticoids (GC) and other pro-inflammatory mediators, are 
released into the blood stream. 
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Infection-induced thymic atrophy 
 
Premature thymic atrophy is a common consequence of infection by viruses, bacteria, 
parasites and fungi (Box 1)18 and can be a local and/or systemic effect. For example, GC 
levels rise during acute infection, and can induce thymocyte apoptosis, especially among 
double-positive (DP) thymocytes19. Adrenalectomy prior to infection prevents thymocyte 
depletion in rabies virus infected mice, which confirms a role for GCs in infection-induced 
thymic atrophy20. Infection-induced premature thymic atrophy also occurs independently of 
increased systemic GC levels. For example, adrenalectomy prior to Toxoplasma gondii 
infection abolishes peripheral lymphopenia but does not prevent thymocyte loss21. In other 
infections, GC synergize with other mediators to induce thymic atrophy. These include TNF 
during Francisella tularensis22 and Trypanosoma cruzi infection23, IFNγ during Salmonella 
enterica infection24, and IFNγ and nitric oxide during Mycobacterium avium infection25.  
Interestingly, infection-induced thymic atrophy often correlates with strain virulence, 
as observed for T. cruzi18, F. tularensis22, M. avium25, measles virus26, highly pathogenic 
avian influenza viruses (HPAIV)7 and simian immunodeficiency virus (SIV)27. These data 
suggest that specific microbial factors directly promote thymocyte death. This is true for 
bacterial factors such as LPS28, Escherichia coli enterotoxin29 and mycobacterial cord 
factor30 and has been confirmed with the fungal virulence factors gliotoxin31 and toxin T-232, 
all of which directly induce thymocyte apoptosis when administered to mice. Local thymic 
effects are also observed after HIV infection2. Interestingly, HIV thymotropic viral variants are 
detected in vivo33, raising the possibility that these strains would be more likely to affect 
thymic function. The infected cell type depends on viral tropism for CXCR4 and CCR5, but 
most thymocyte subsets can become infected2. HIV also infects different thymic stromal cells, 
including macrophages, both conventional (cDC) and plasmacytoid DC (pDC) – and thymic 
epithelial cells (TEC)34-36. HIV affects the fate of infected cell types differently. For example, 
CD4SP thymocyte depletion results from direct infection, killing of progenitor cells, and 
apoptosis induction of uninfected cells by viral products37. HIV infection also induces DC and 
TEC death34,36. In the case of DC, cell death is associated with IFNα production by pDC but 
not cDC34. Thus, in addition to inducing thymocyte death, HIV disrupts thymic function by 
altering the local microenvironment. Collectively, these data show that HIV infection induces 
thymic atrophy and impacts thymic function, leading to a decline in the export of newly 
differentiated T cells2,38. 
Similar to HIV, murine leukemia virus (MLV) has specific LTR region sequences that 
affect viral infection and replication in DP and DN thymocytes and in other thymic 
populations39. MLV induces apoptosis of infected cells within the thymus even before the 
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leukemic period. Apoptosis is induced by the accumulation of Env protein precursors, 
triggering endoplasmic reticulum stress40. Thus, apoptosis is a consequence of local 
infection, and infected DP cells die more than uninfected cells within the thymus. 
Thymic atrophy is also detected during infection with HPAIV7. These viruses cause 
severe human disease accompanied by profound lymphopenia. After intranasal challenge of 
mice, influenza-infected DC are present in the cortico-medullary region and medulla of the 
thymus. Thymic atrophy is strain dependent and occurs only after infection with highly 
pathogenic virus. HPAIV interferes with thymic function, inducing loss of DP thymocytes and 
diminished export of naïve T cells to the periphery, leading to severe lymphopenia. It is 
unknown what role GCs play during this acute infection and the relative contribution of local 
versus systemic factors to thymic atrophy cannot be ascertained. 
These studies demonstrate that local and systemic effects can induce thymic atrophy 
during infection, and are not mutually exclusive.  
 
Thymic structure is altered by infection 
 
Infection induces thymic structural alterations other than atrophy. For example, both 
T. cruzi and Plasmodium berghei directly infect the thymus and induce significant changes in 
the extracellular matrix18,41-43. T. cruzi increases fibronectin and laminin deposition and 
CXCL12 and CCL4 production within the thymus43,44. During T. cruzi infection, expression of 
the fibronectin and laminin receptors (VLA-4, VLA-5 and VLA-6) and CXCR4 and CCR5 is 
augmented on thymocytes and intrathymic thymocyte migration of DP cells is enhanced43,44. 
P. berghei affects thymocyte migration by inducing CXCL12 and CXCR4 and reducing 
CCL25 and CCR9 production within the thymus42. When analyzed ex vivo, both DN and SP 
cells from infected thymi migrate faster than control populations towards extracellular matrix 
components42. In both cases, these changes affect peripheral T cell subsets. At the peak of 
T. cruzi infection, a higher frequency of immature and VLAhi DP T cells are found in the 
periphery43. Similarly, increased numbers of DN and DP T cells are found in the periphery of 
P. berghei infected mice41.  
Viral infections also induce significant changes in thymic structure by infecting cells in 
stromal cells45. HIV can infect TEC and lead to degeneration of these cells36. Hepatitis 
virus46, MLV47, measles virus48, CMV49  and type-B Coxsackievirus (CV-B)50 also infect TEC. 
Interestingly, in vitro infection of human TEC with measles virus results in terminal 
differentiation and apoptosis of these cells48. In contrast, in vitro CV-B infection of human 
TEC does not cause damage but modulates cell function, leading to increased production of 
IL-6, GM-CSF and leukocyte migration inhibition factor (LIF)50. The observation that viruses 
infect TEC, alter their function, and in some cases induce cell death, is especially important 
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given the crucial role these cells play in T cell development51. Finally, the changes in thymic 
cellularity observed during viral infection may be caused by depletion of TEC and secondary 
decline in thymocyte number.  
These data show that structural alterations of the thymus caused by infection modify 
the characteristics of differentiating T cells and affect T cell export. 
 
Alterations in thymic export 
 
The appearance of DP thymocytes in the periphery, as described following T. cruzi 
and P. berghei infection, is also a hallmark of infections caused by HIV, hepatitis B (HBV) 
and hepatitis C (HCV) virus52. These viruses can be detected within the thymus (Table 1), 
and although the origin of peripheral DP cells is unknown, one possibility is that they are 
released from the thymus after local infection. Alternately, activated T cells may acquire a 
DP phenotype as observed during HIV and other infections53. Whether peripheral DP cells 
are an indication of altered thymic function or whether they represent activated T cells likely 
varies according to the infecting agent and requires experimental determination. 
Alterations in thymic structure due to infection can alter T cell export in other ways. A 
major consequence of HIV infection is reduced export of recent thymic emigrants, an effect 
confirmed by T cell rearrangement excision circles (TREC) analysis2,38. Since thymic activity 
is essential to maintain or reconstitute a functional peripheral T cell pool, interventions that 
enhance this process may potentiate the beneficial effects of anti-retroviral therapy on 
immunity54.  
Although it's intuitive that reduced thymic T cell export is a consequence of infection-
induced thymic atrophy, this is not always the case. During Salmonella-induced thymic 
atrophy, T cell export is maintained55, suggesting that atrophy and a decline in thymic 
function might be independent. Nevertheless, maintaining thymic export of recent thymic 
emigrants during infectious episodes is important, as it positively impacts ongoing 
immunity13-17. 
 
Generation of T cells tolerant to pathogens 
 
 We’ve shown how infection alters thymic structure and affects export of immature 
and naïve T cells. Another important question is whether infection of the thymus and the 
presence of microbial antigens in the thymus, particularly during persistent infection, leads to 
pathogen-specific tolerance. This question was investigated using a model of mycobacterial 
infection. Infection of mice with M. avium of intermediate virulence leads to chronic 
persistent infection. During this infection, M. avium disseminates to, and persists in, the 
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thymus25,56. No thymic atrophy occurs and the chronically infected thymus continues to 
support T cell differentiation. However, T cells that mature in infected thymi are abnormal as 
they suboptimally respond to M. avium antigens compared to T cells that differentiate in 
uninfected thymi. Importantly, T cells that differentiate in M. avium infected thymi respond 
normally to unrelated antigens, indicating that the defect is specific for the invading 
pathogen11. Although the precise mechanism(s) responsible for this difference is still being 
elucidated, these data demonstrate that thymic infection can induce pathogen-specific T cell 
tolerance. 
Tolerance to invading pathogens is also observed during viral infection. Neonatal 
MLV infection leads to infection of thymocytes as well as thymic stromal cells and renders T 
cells tolerant to virus antigens47. Similarly, congenitally acquired LCMV infection is a model 
of immune tolerance: mice infected in utero or at birth show high viral titers in most organs, 
including the thymus, and have a selective defect in LCMV-specific T-cell immunity57. LCMV 
infection of the thymus starts at the fetal stage in DN cells, and transitions to CD4+ T cells in 
the adult thymus. In contrast, CD8+ T cell infection is minimal58, and transferred virus-specific 
cytotoxic T lymphocytes (CTL), from immunized mice, infiltrate the thymus and eliminate the 
infection6,57. In this model, viral clearance is associated with reacquisition of LCMV-specific 
CTL responses, suggesting that continuous presence of the antigen in the thymus is 
required to maintain tolerance, not only during fetal development but in adult animals as well. 
Viral hepatitis also induces central tolerance to HBV. While acute infection in adults 
is readily resolved, HBV infection in utero induces tolerance to viral proteins, and infants 
born to HBV-infected mothers are more likely to become chronic carriers of HBV59,60. One 
explanation is that viral proteins in the neonatal thymus induce HBV-specific T cell tolerance. 
Significantly, both MLV and HBV infect TEC46,47, which could explain why these infections 
induce T cell tolerance while others do not. Since TEC turnover is rapid61 this hypothesis 
implies that these viruses can continually infect new TEC or reside in thymic epithelial stem 
cells.  
These data suggest that direct infection of the thymus by virus and bacteria alter T 
cell selection and induce tolerance against the invading pathogen, with the potential to 
impair ongoing immunity. An interesting question is whether the mechanism of tolerance 
induced by thymic infection involves the generation of pathogen-specific regulatory T cells, T 
cell anergy or negative selection of differentiating pathogen-reactive T cells. 
 
Autoimmunity induced by thymic infection 
 
Pathogens that disrupt thymic function may also disrupt the development of central 
tolerance. Autoreactive T cells that are normally negatively selected in the thymus might 
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escape death because of thymic dysfunction, emigrate to the periphery, and trigger 
autoimmunity. While this possibility remains theoretical, some data supports it. During 
experimental T. cruzi infection, T cells expressing ‘‘forbidden’’ TCRs that are normally 
deleted in the thymus, particularly those belonging to the Vβ5 and Vβ12 families, survive and 
can be detected in peripheral LNs. Importantly, thymic SP cells from infected mice are not 
enriched in those TCRs. These data indicate that the appearance of these “prohibited” TCRs 
in the periphery is not due to defective negative selection but a consequence of abnormal 
migration of immature cells62. In addition, anti-thymus antibodies and myocardium-specific 
autoreactive T cells are detected following T. cruzi infection18, raising the possibility that 
infection-induced thymic alterations potentiate autoimmunity. 
 
Thymic infection: the beginning and the end 
 
We next turn our attention to how these various microbes are able to reach the 
thymus and establish infection. Furthermore, if dissemination to the thymus occurs 
commonly during infection, has the immune system evolved mechanisms to respond to 
pathogens invading the thymus? 
 
How do microorganisms reach the thymus? 
 
Two scenarios are possible when considering the origin of thymic infection during 
hematogenous spread of infection. First, circulating pathogens can enter the thymus and 
infect cells in a targeted manner, as represented by thymotropic variants of HIV33 and MLV39. 
Alternately, there is the “Trojan Horse” model. The trafficking of several cell types between 
the periphery and the thymus make this possible. T cells re-circulate from the periphery to 
the thymus63, and if infected, could seed the thymus with pathogens that target T cells (e.g., 
HIV). Similarly, certain DC subsets (e.g., Sirpα+ cDCs) migrate from the periphery to the 
thymus and modulate T cell tolerance64. Interestingly, DC infected with influenza virus or M. 
avium can be detected within thymus, raising the possibility that infected DC spread the 
infection7,11. DC are responsible for disseminating M. tuberculosis from the lung to the 
draining lymph node65, and it is possible that dissemination to the thymus occurs by a similar 
mechanism. Together, these data support the idea that cells circulating to the thymus can 
carry infectious agents and seed thymic infection. An important corollary is that the route and 
duration of infection may modify the risk that the thymus becomes infected by different 
pathogens. 
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Immunity within the thymus 
 
If the thymus is a site of infection, it may recruit an immune response against 
invading pathogens. As discussed, during systemic LCMV infection, LCMV-specific CTL 
traffic to the thymus, establish an immune response, and eliminate LCMV from the 
thymus6,57. Similarly, during influenza infection, functional influenza-specific CTLs are 
detected within the thymus7. Finally, antigen-specific CD4+ and CD8+ T cells are detected in 
the thymus following M. avium and M. tuberculosis infection, as part of the immune response 
against persistent bacteria4,5. Importantly, the responding T cells in the thymus are not newly 
differentiated mature thymocytes but instead are activated T cells that recirculate from 
peripheral organs to the thymus to fight infection4. Under these conditions, the recruitment of 
activated T cells is associated with increased expression of T helper 1 chemokines and an 
enrichment of CXCR3+ mycobacteria-specific T cells within the thymus4. These results 
confirm that the thymus is not only a site of infection, but suggest that it is actively surveyed 
by the immune system. 
 
Final remarks  
 
The recent studies reviewed here show that the thymus is a site of infection that has 
important immunological consequences. Pathogens disrupt thymic structure and function, 
and alter T cell selection and export. These changes affect the peripheral T cell pool and 
affect ongoing and future immune responses. 
These data suggest a model in which the effect of infection on the thymus depends 
on the type of microbe, the severity of infection and the ability of the pathogen to infect and 
persist within the infected thymus (Figure 1). In this scheme, acute infection is characterized 
by increased GC and pro-inflammatory mediator levels, which can lead to thymic atrophy. 
This effect is more pronounced on DP cells and can occur even in the absence of the 
pathogen in the thymus. Local thymic infection can exacerbate atrophy, through remodeling 
of extracellular matrix, production of virulence factors or direct infection of thymic cells. 
These structural changes affect thymic function; particularly T cell export, leading to the 
release of immature (DP/DN) or autoreactive T cells into the periphery. Despite the profound 
effects of acute infection on the thymus, the impact of thymic dysfunction on immunity is 
predicted to be limited and transient as the peripheral T cell pool should include pre-existing 
pathogen-specific T cells. In contrast, local thymic infection may have severe repercussions, 
particularly for: 1) infections acquired during childhood – when the T cell repertoire is still 
developing; 2) in the setting of persistent infection (e.g., tuberculosis), which may induce to T 
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cell tolerance; 3) infections associated with severe lymphopenia (e.g., HIV), when lymphoid 
reconstitution is required. In these cases, emergence of central tolerance to the infectious 
agent may impair deployment of pathogen-reactive T cells in the naïve repertoire. Such a 
scenario could favor the microbe, since impairment of T cell immunity would contribute to 
pathogen persistence. In order to minimize such consequences, mechanisms exist to 
respond to direct infection of the thymus (Figure 2). Just as in other tissues, these rely on 
the trafficking of peripheral T cells from secondary lymphoid tissue back to the thymus. 
While required for protection, circulation of cells back to the thymus could allow some 
pathogens access to the thymus.  
Altogether, preserving a sterile thymic environment is essential to maintain thymic 
integrity, both structurally and functionally, sustain optimal T cell differentiation and export, 
and prevent the emergence of tolerance to invading pathogens. Therefore, the thymus 
should be regarded as an active player during infectious episodes and the contribution of 
this organ for ongoing immunity should be addressed in future studies (Box 2). 
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Boxes 
 
Box 1. Mechanisms of thymic atrophy.  
Thymic atrophy, or involution, refers to the decrease in size of the thymus, and 
usually correlates with a decline in thymic function, resulting in a reduced export of naïve T 
cells to the periphery. Although involution is a physiological process, and the thymus 
normally atrophies with aging and pregnancy, several non-physiological stimuli can induce 
thymic atrophy, such as stress and infection. Infection-induced atrophy occurs by at least 
two different mechanisms: alterations in TEC or induction of apoptosis in thymocytes, 
particularly DP cells. Why thymic atrophy should accompany infection is debated. The 
different hypotheses include: (1) thymic atrophy is a by-product of infection, with no specific 
advantage for the pathogen or the host; (2) thymic atrophy is a virulence strategy employed 
by pathogens to subvert antimicrobial immunity; and (3) thymic atrophy is a host strategy 
that reduces thymic activity during infection to prevent disruption of T cell selection and 
prevent the emergence of central tolerance to the invading organism. In any case, thymic 
atrophy can impair thymic function and has implications for ongoing immunity. 
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Box 2. Outstanding questions.  
 How universal is thymic infection? Do other pathogens infect the thymus?  
 How does the thymus get infected? Do pathogens directly target the thymus, or do 
they disseminate inside recirculating cells?  
 Why does atrophy accompany thymic infection so frequently? Is atrophy beneficial 
for the host or the bug? 
 What are the mechanisms responsible for T cell tolerance? Does the presence of 
microbial antigens lead to negative selection of developing T cells? Do microbe-specific 
Tregs emerge following thymic infection? Are developing T cells anergic to the infectious 
agent? 
 How does infection of the thymus impact ongoing immunity? Does thymic infection 
during childhood impact immunity later in life? Is thymic infection relevant during 
vaccination?  
 How important are newly generated T cells during chronic infections and during 
immune reconstitution? 
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Figures 
 
 
Figure 1. The effects of infection on the thymus. Schematic representation of how 
infection can affect the thymus through systemic and/or local effects. Glucocorticoids and/or 
pro-inflammatory mediators mediate systemic effects, while local effects require the 
presence of a pathogen within the thymus. Infection-induced alterations include thymic 
atrophy, modifications in the thymic structure and alterations in the T cells exported to the 
periphery. Representative pathogens capable of inducing the different alterations in thymic 
structure and/or function are indicated. DN – double negative. DP – double positive. 
 
Figure 2. Immune response in the thymus. Schematic representation of microbial 
dissemination and recruitment of an immune response to the thymus. Under normal 
conditions, mature T cells and DC re-circulate from peripheral lymphoid organs to the 
thymus (left panel). Following infection, pathogens disseminate from the periphery to the 
thymus, either extracellularly or within re-circulating cells. The infected thymus produces 
chemokines, such as CXCL9 and CXCL10, which recruit CXCR3-expressing antigen-
specific T cells from the peripheral tissues back to the thymus to fight infection (right panel). 
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Table 1. Pathogens that infect the thymus. Virus, bacteria, fungi and parasites have been 
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Figure 1. The effects of infection on the thymus. Schematic representation of  how 
infection can affect the thymus through systemic and/or local effects. Glucocorticoids and/or 
pro-inflammatory mediators mediate systemic effects, while local effects require the 
presence of  a pathogen within the thymus. Infection-induced alterations include thymic 
atrophy, modifications in the thymic structure and alterations in the T cells exported to the 
periphery. Representative pathogens capable of inducing the different alterations in thymic 
structure and/or function are indicated. DN – double negative. DP – double positive.
Figure 2. Immune response in the thymus. Schematic representation of  microbial 
dissemination and recruitment of an immune response to the thymus. Under normal 
conditions, mature T cells and DC re-circulate from peripheral lymphoid organs to the 
thymus (left panel). Following infection, pathogens disseminate from the periphery to the 
thymus, either extracellularly or within re-circulating cells. The infected thymus produces 
chemokines, such as CXCL9 and CXCL10, which recruit CXCR3-expressing antigen-
specific T cells from the peripheral tissues back to the thymus to fight infection (right panel). 
LN – lymph node. 
Table 1. Pathogens that infect the thymus. Virus, bacteria, fungi and parasites have been 
documented to infect the thymus, either in humans or experimental animal models. The 
major consequences of  each infection on thymic structure or function are listed, when 
available. DN – double negative. DP – double positive.

Chapter 3 
T cells home to the thymus and control infection
How the thymus controls mycobacterial infection
(Published in The Journal of Immunology, 2013 Feb 15;190(4):1646-58)
In chapter 2, we review data on multiple microbes that infect the 
thymus and alter thymic structure and function. However, if 
dissemination to the thymus is a common consequence of 
infection, with potentially severe implications for ongoing immunity, 
the immune system must have evolved mechanisms to control or 
contain the invading pathogens. That is the subject of this chapter, 
in which we report how the immune system recruits peripheral T 
cells back to the thymus in order to mount immune responses that 
control mycobacterial infection in this organ.
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Abstract 
 
 The thymus is a target of multiple pathogens. How the immune system responds to 
thymic infection is largely unknown. Despite being considered an immune privileged organ, 
we detect a mycobacteria-specific T cell response in the thymus following dissemination of 
Mycobacterium avium or Mycobacterium tuberculosis. This response includes pro-
inflammatory cytokine production by mycobacteria-specific CD4+ and CD8+ T cells, which 
stimulates infected cells and controls bacterial growth in the thymus. Importantly, the 
responding T cells are mature peripheral T cells that recirculate back to the thymus. The 
recruitment of these cells is associated with an increased expression of Th1 chemokines and 
an enrichment of CXCR3+ mycobacteria-specific T cells in the thymus. Finally, we 
demonstrate it is the mature T cells that home to the thymus that most efficiently control 
mycobacterial infection. Although the presence of mature T cells in the thymus has been 
recognized for some time, these data are the first to show that T cell recirculation from the 
periphery to the thymus is a mechanism that allows the immune system to respond to thymic 
infection. Maintaining a functional thymic environment is essential to maintain T cell 
differentiation and prevent the emergence of central tolerance to the invading pathogens. 
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Introduction 
The appearance of adaptive immunity in jawed vertebrates is considered a major 
step in the evolution of the immune system, as it provides the host with a crucial tool to 
combat microbial pathogens: namely B and T lymphocytes [reviewed in (1, 2)]. B and T 
lymphocytes express antigen receptors that result from the recombination of germline 
encoded gene segments, which establishes a diverse repertoire of antigen receptors. This 
allows B and T cell antigen receptors to recognize antigens the host has not previously 
encountered. The TCRs, which recognize short linear peptide fragments in the context of 
antigen presenting molecules (class I or II MHC), allow the host to survey both the intra- and 
extracellular environment. 
The diverse repertoire of TCRs, which are generated by genetic recombination, 
creates specific challenges for the immune system. First, not all TCRs generated will 
recognize self-MHC/peptide complexes. Second, some TCRs will recognize self-
MHC/peptide complexes with such a high affinity/avidity that will render them potentially 
autoreactive. To avoid full differentiation of T cells with these unwanted characteristics, 
thymocytes go through a complex process of selection during their differentiation in the 
thymus. T cell precursors emerge from the bone marrow and home to the thymus, a primary 
lymphoid organ that exists for the purpose of supporting T cell differentiation. Two 
fundamental selection processes occur during T cell differentiation in the thymus – positive 
and negative selection [reviewed in (3)]. The outcome of thymic selection depends on the 
organ microenvironment including which antigens are present within the thymus and the 
cytokine milieu surrounding the differentiating cells. Positive selection creates a pool of 
thymocytes that bind self-MHC/peptide complexes while T cells expressing TCRs that fail to 
bind these complexes undergo cell death by apoptosis. T cells expressing TCRs that bind 
self-MHC/peptide complexes with high affinity/avidity are also eliminated through negative 
selection. This process of central tolerance is essential to generate a repertoire of T cells 
that is self-restricted and self-tolerant, and which limits the development of potentially 
autoreactive T cells. Thus, proper thymic activity is crucial for the development and 
maintenance of a repertoire of functional T cells. Infants born with genetic mutations that 
abrogate T cell differentiation are profoundly susceptible to infection, which confirms the 
essentiality of T cells for cell-mediated immunity (4). 
Thymic activity decreases naturally with age, although the adult thymus still supports 
T cell differentiation and T cells continue to be exported into the peripheral T cell pool (5, 6). 
Coincident with T cell differentiation and thymic activity, the developing immune system is 
assaulted by various microbial pathogens. In fact, thymic function is affected during infection 
by several pathogens, including species of bacteria, virus, fungi and parasites (7, 8). Both in 
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humans and animal models the thymus is itself a target of infection (7-19). Infection of the 
thymus by mycobacterial species has been reported both in humans (16) and in animal 
models (17-19). The incidence of thymic infection during active tuberculosis is unknown 
although there are several case reports in the clinical literature (16). However, it is relevant 
that vertical transmission of tuberculosis (mother to child) frequently occurs during early 
childhood, at the height of thymic activity (20). 
Although the thymus has been formerly considered an immune privileged site (21), 
this idea is being reconsidered. In fact, it is clear that protection of the thymus from infection, 
particularly during childhood, a time of diverse and recurrent infection, should be a function 
of the immune system. Since negative selection of T cells depends on the antigens 
encountered in the thymus during differentiation, infection of this organ could theoretically 
lead to the development of immune tolerance to pathogens. How the immune system 
prevents, or combats thymic infection, to maintain the organ’s integrity and function, and 
keep it free from microbial antigens is still unclear. Interestingly, the thymus does contain 
several populations of mature T cells. These include innate lymphocytes such as iNKT cells 
(22), γδ T cells (23), and MR1-restricted MAIT cells (24), all of which have been implicated in 
host defense against infection. In addition, there are recirculating conventional CD4+ and 
CD8+ T cells (25). Why mature T cells should recirculate back to the thymus is unknown, 
although others have hypothesized that these T cells play a role in surveying the thymus for 
infection [reviewed in (25-27)]. 
 Despite the introduction of BCG vaccination a century ago and the development of 
multiple pharmacological drugs that are active against mycobacteria, these bacteria are still 
one of the most prevalent infectious agents worldwide (28). Among these, Mycobacterium 
tuberculosis alone is estimated to cause approximately 8.8 million new infections and 1.4 
million deaths per year (28). In addition to M. tuberculosis, other members of the 
Mycobacterium genus including Mycobacterium marinum, Mycobacterium ulcerans, 
Mycobacterium leprae and Mycobacterium avium cause disease in humans (29). Some of 
these are opportunistic infections and mainly affect immunocompromised individuals (30). In 
fact, the spread of HIV dramatically increased the prevalence of active mycobacterial 
infection, which is the main cause of death in patients with AIDS (31). 
We previously showed that experimental infection with M. tuberculosis and M. avium 
leads to the establishment of thymic infection in chronically infected mice (18, 19). Now we 
report that infection of the thymus is followed by the establishment of protective immunity 
within the thymus, characterized by the appearance of both CD4+ and CD8+ T cells specific 
for mycobacterial antigens. These antigen-specific T cells do not originate from the pool of 
differentiating T cells in the thymus, but are instead T cells that recirculate from peripheral 
organs back to the infected thymus to control infection. Their recruitment to the thymus 
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correlates with the expression of the chemokine receptor CXCR3 and the production of 
CXCL9 and CXCL10 by the infected thymus. These data are the first to show that T cell 
recirculation to the thymus is a mechanism used by the immune system to survey and 
protect the thymus from infection and maintain thymic integrity. 
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Materials and Methods  
 
Mice and infection 
C57BL/6 (WT) mice were purchased from Charles River Laboratories (Barcelona, Spain) or 
from Jackson Laboratories (Bar Harbor, ME) and CD45.1 mice (B6.SJL-Ptprca 
Pepcb/BoyJ)(32) and TCRα KO (B6.129S2-Tcratm1Mom/J) from The Jackson Laboratory (Bar 
Harbor, ME)(33). RAG-GFP mice (34) were kindly provided by Dr. António Bandeira 
(Pasteur Institute, Paris, France). Both TCRα KO and RAG-GFP mice were bred in our 
facilities. Mice were 7 to 10 weeks old at the start of the experiments. All animal experiments 
were performed in accordance with National and European Commission guidelines for the 
care and handling of laboratory animals and were approved by the National Veterinary 
Directorate and by the local Animal Ethical Committee or by the Dana Farber Cancer 
Institute Animal Care and Use Committee (Animal Welfare Assurance no. A3023-01), under 
Public Health Service assurance of Office of Laboratory Animal Welfare guidelines. Mice 
infected with M. tuberculosis were housed in a biosafety level 3 facility under specific 
pathogen-free conditions at the Animal Biohazard Containment Suite (Dana Farber Cancer 
Institute, Boston, MA). 
 
Experimental infection 
M. avium (strain 2447, provided by Dr. F. Portaels, Institute of Tropical Medicine, Antwerp, 
Belgium) infection was performed intravenously through the lateral tail vein delivering 106 
CFU per mouse. For each M. tuberculosis (Erdman strain) infection, a bacterial aliquot was 
thawed, sonicated twice for 10 s in a cup horn sonicator, and then diluted in 0.9% NaCl–
0.02% Tween 80. A 15 ml suspension of M. tuberculosis was loaded into a nebulizer 
(MiniHEART nebulizer; Vortran Medical Technologies) and mice were infected via the 
aerosol route using a nose-only exposure unit (Intox Products) and received 100–200 
CFU/mouse. At different times post-infection, mice were euthanized by carbon dioxide 
inhalation or by decapitation and organs were aseptically removed, individually 
homogenized and viable bacteria were enumerated by plating 10-fold serial dilutions of 
organ homogenates onto 7H10 or 7H11 agar plates for M. avium and M. tuberculosis, 
respectively. Plates were incubated at 37ºC and M. avium and M. tuberculosis colonies were 
counted after 7 and 21 d, respectively. 
Gene expression analysis 
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Total RNA was isolated from thymi, spleens and lungs using TRIZOL reagent or TRIZOL 
Plus RNA purification system (Invitrogen, CA, USA). Five hundred nanograms of total RNA 
were amplified using the Superscript RNA amplification system (Invitrogen CA, USA) 
according to the manufacturer’s instructions. mRNA transcripts were assessed by 
quantitative real-time PCR (qPCR) using SsoFast™ EvaGreen Supermix® (BioRad, CA, 
USA) in a BioRad CFX96™ Real-Time System with a C1000™ Thermal Cycler or a 
Stratagene Mx3005P Thermal Cycler. The hypoxanthine guanine phosphoribosyl 
transferase (HPRT) was used as reference gene. Specific oligonucleotides were used for 
Hprt (sense: 5’-GCT GGT GAA AAG GAC CTC T-3’; antisense: 5’-CAC AGG ACT AGA 
ACA CCT GC-3’), Ifnγ (sense: 5’-CAA CAG CAA GGC GAA AAA GG-3’; antisense: 5’-GGA 
CCA CTC GGA TGA GCT CA-3’), Tnf (sense: 5’-TGC CTA TGT CTC AGC CTC TTC-3’; 
antisense: 5’-GAG GCC ATT TGG GAA CTT CT-3’), Cxcl9 (sense: 5’-CTT TTC CTC TTG 
GGC ATC AT-3’; antisense: 5’-GCA TCG TGC ATT CCT TAT CA-3’), Cxcl10 (sense: 5’-
GCT GCC GTC ATT TTC TGC-3’; antisense: 5’-TCT CAC TGG CCC GTC ATC-3’), Ccl4 
(sense: 5’-AGC ACC AAT GGG CTC TGA-3’; antisense: 5’-TTT GGT CAG GAA TAC CAC 
AGC -3’) and inducible nitric oxide synthase (Inos; sense: 5’-CTC GGA GGT TCA CCT CAC 
TGT-3’; antisense: 5’-GCT GGA AGC CAC TGA CAC TT-3’). The cDNA was denatured for 
1 min at 95 °C, followed by 40 cycles of 95 °C for 15 s, incubation at the optimized melting 
temperature for 20 s, and 72 °C for 20 s. Optimized melting temperatures were 57 °C for 
Cxcl9 and Ccl4, 58 °C for Hprt, Ifnγ and Cxcl10 and 59 °C for Inos. The expression level of 
each gene was determined using the ΔΔCt method taking into account the efficiency of the 
PCR reaction (35). Data are represented as the ratio of the expression level of the gene for 
each infected mice over the mean expression level of the gene in uninfected mice.  
 
Protein quantification in tissue homogenates 
Protein was extracted from spleen, lung and thymus using the Bio-Plex Cell Lysis kit (Bio-
Rad, CA, USA) and the concentration of IFNγ, TNF and CCL4 were measured using a 
mouse Bio-Plex cytokine assay (Bio-Rad, CA, USA). In the case of M. tuberculosis-infected 
tissues, the concentrations of CXCL9 and CXCL10 were measured using the mouse 
CXCL9/MIG Quantikine ELISA Kit or mouse CXCL10/IP-10/CRG-2 Quantikine ELISA Kit 
(R&D Systems, MN, USA).  
Immunohistochemistry 
Detection of iNOS was performed by immunohistochemistry in paraformaldehyde fixed, 
paraffin embedded tissues. Briefly, 5 µm thymic sections were dehydrated and antigens 
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were ‘unmasked’ by incubation at 96 °C for 30 min in 1 mM EDTA 0.05% Tween pH 8. Non-
specific binding was blocked using 4% BSA in PBS with 0.05% Tween 20 and endogenous 
peroxidases were blocked by incubation with 3% hydrogen peroxide for 30 min. Tissues 
were incubated overnight, at 4 °C, with purified rabbit anti-mouse iNOS (clone M-19, Santa 
Cruz Biotechnology, CA, USA) and detection was performed using a peroxidase goat anti-
rabbit IgG (Vector Labs, CA, USA) followed by incubation with DAB until color development. 
Mycobacteria were detected by Ziehl-Neelsen, using standard procedures, after the iNOS 
staining. Slides were visualized using a BX61 microscope with an Olympus DP70 camera. 
No significant signal was observed when iNOS stain was performed in iNOS KO mice. 
 
In vitro stimulation and IFNγ measurement by ELISA 
Cell suspensions from thymus and spleen were prepared by gentle disruption of the organs 
between two notched slide glasses or by forcing organs through a 70 µm nylon strainer 
(Fisher). For lung preparations, tissue was digested for 1 h at 37 °C in 1 mg/mL collagenase 
(Sigma) prior to straining. Erythrocytes were lysed using a hemolytic solution (155 mM 
NH4Cl, 10 mM KHCO3, 0.1 mM sodium EDTA pH 7.2) and, after washing, cells were 
resuspended in supplemented DMEM or RPMI (10% heat inactivated FCS, 10 mM HEPES, 
1 mM sodium pyruvate, 2 mM L-glutamine, 50 mg/ml streptomycin and 50 U/ml penicillin, all 
from Invitrogen). Cells were enumerated in 4% trypan blue on a hemocytometer or on a 
Countess Automatic Cell Counter (Life Technologies). 5×105 cells were plated in each well 
of a 96-well plate and incubated, in triplicate, in the presence M. avium total extract proteins 
(4 µg/ml), Ag85280-294 peptide (4 µg/ml; Metabiom, Germany) (36), TB10.44-11 peptide (10 µM; 
New England Peptide) (37) or ESAT-61-20 peptide (10 µM; New England Peptide) (38). 
Incubation in the presence of Concanavalin A (4 µg/ml; Sigma) or αCD3/αCD28 (1 mg/mL; 
BioLegend) or in the absence of stimuli were used as positive and negative controls, 
respectively. Supernatants were collected after 72 h of culture and the concentration of IFNγ 
was determined by ELISA (R4-6A2 and biotinylated AN18 were used as capture and 
detection Abs, respectively, from eBiosciences; or using the Mouse IFNγ ELISA MAX 
Standard kit, from Biolegend).  
Flow cytometry 
Surface staining was performed with antibodies specific for mouse CD3 (145-2C11), CD4 
(RM4-5), CD8 (53-6.7), CD24 (M1/69), CD44 (IM7) and CXCR3 (CXCR3-173) (from 
Biolegend, CA, USA, or from BD Pharmingen, CA, USA). The tetramers Ag85280-294-loaded I-
Ab and TB10.44–11-loaded H-2 Kb were obtained from the National Institutes of Health 
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Tetramer Core Facility (Emory University Vaccine Center, Atlanta, GA, USA); staining was 
performed for 30 min at 37 °C before incubation with the antibodies mix for the Ag85280-294-
loaded I-Ab tetramer or for 20 min on ice during the incubation with the surface antibodies for 
the TB10.44–11-loaded H-2 Kb tetramer. All stainings, except the one with the Ag85280-294-
loaded I-Ab tetramer, were fixed before acquisition with 2% formaldehyde in PBS for 30 min. 
Cell analysis was performed on a LSRII flow cytometer or on a FACS Canto using FACS 
Diva Software (Becton Dickinson, NJ, USA). Data were analyzed using FlowJo Software 
(Tree Star, OR, USA). Single-lymphocyte events were gated by forward scatter versus 
height and side scatter for size and granularity. 
 
Thymic transplant 
Thymic lobes were aseptically removed from WT mice and kept in cold supplemented 
DMEM until being transplanted under the kidney capsule of anesthetized TCRα KO mice 
(200 µg xylazine hydrochloride and 200 µg ketamine hydrochloride, administered i.v.). 
 
T cell chimeras 
Single cell suspensions of pools of spleen and thymus from M. avium infected RAG-GFP 
mice (20 to 22 wpi) were prepared. CD4+ T cells were purified from each suspension using 
the CD4+ T cell isolation kit for spleenocytes or CD8a (Ly-2) microbeads (both from Miltenyi 
Biotec, Germany) for thymocytes. Magnetic separation was performed with an autoMACS 
separator (Miltenyi Biotec, Germany). After purification, cells were counted and stained with 
antibodies for CD3, CD4, CD8 and CD24 for sorting. Splenic CD4+CD8-CD3+ cells, thymic 
CD4+CD8-CD3+RAG-CD24lo cells and thymic CD4+CD8-CD3+RAGint cells were sorted using 
a FACSAria cell sorter (Becton Dickinson, NJ, USA) with a purity ranging from 98 to 100%, 
depending on the experiment and on the population. 4 to 4.2×105 cells were transferred per 
TCRα KO receptor mouse. 
Adoptive transfer of CXCR3-expressing T cells 
Single cell suspensions of pools of spleens from M. tuberculosis infected B6 mice (20 to 26 
wpi) were prepared. Total T cells were purified from each suspension using the T cell 
isolation kit II (from Miltenyi Biotec, Germany). Magnetic separation was performed with an 
autoMACS separator (Miltenyi Biotec, Germany). After purification, cells were counted and 
7×107 cells were transferred intravenously to each recipient. Recipient mice (CD45.1) had 
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been infected for 12 weeks, and were analyzed 24 h following transfer. After sacrifice, 
magnetic bead-based enrichment was performed on single cell suspensions of thymocytes, 
as previously described (39). Briefly, cells were stained with a PE-labeled antibody specific 
for mouse CD45.2 (104) (from Biolegend, CA, USA), followed by incubation with anti-PE 
beads (from Miltenyi Biotec, Germany). Magnetic separation was performed with an 
autoMACS separator (Miltenyi Biotec, Germany). The bound fraction, enriched for donor 
cells, was analyzed by FACS (as described above). 
 
Statistical analysis 
All data are represented as mean + SEM. Data were verified for Gaussian distribution or 
Mann-Whitney U test were performed to compare two groups. To compare more than 2 
groups, one-way ANOVA, followed by Bonferroni post-hoc test was performed. Differences 
with a p<0.05 were considered significant and represented by *. 
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Results 
 
Thymic integrity is maintained following mycobacterial infection. 
The ability of mycobacteria to disseminate to the thymus has been previously 
described upon aerosol challenge with M. tuberculosis [Figure 1A and (18)] and following 
intravenous infection with M. avium (18, 19). In both cases the bacterial load in the thymus is 
initially low or undetectable, but increases profoundly until it plateaus, in a pattern similar to 
the one observed in the lung and spleen, indicative of immunological restriction of bacterial 
replication. However, bacterial dissemination to the thymus is delayed compared to other 
organs, and peaks late during the course of infection – 16 weeks post infection (wpi) for M. 
avium (18, 19) and 12 wpi for M. tuberculosis (Figure 1A). In addition, thymic infection by M. 
tuberculosis is also more heterogeneous, with a small fraction of mice having undetectable 
bacterial load within the thymus even at 24 wpi (Figure 1A). The fact that we did not observe 
this heterogeneity previously (18) might be a consequence of the greater number of animals 
studied in the present experiments or of slight differences in the infection protocol (different 
M. tuberculosis strains and/or different apparatus used for aerosol infection). 
As previously observed for M. avium infection with a low virulence strain (19), 
infection with M. tuberculosis does not induce loss of thymic cellularity even at 24 wpi, as 
compared to uninfected age-matched controls (Figure 1B). Percentages of the four main 
thymic populations - assessed by CD3, CD4 and CD8 expression [CD4-CD8-CD3- double 
negative (DN); CD4+CD8+CD3low/- double positive (DP); CD4+CD8-CD3+ single positive CD4 
(CD4SP); CD4-CD8+CD3+ single positive CD8 (CD8SP)] – are also maintained following 
infection, although a small increase in the percentages of SP cells, both CD4SP and CD8SP, 
and decrease in DP, is observed from 12 wpi on (Figure 1C). These data indicate that the 
presence of M. tuberculosis within the thymus does not induce premature thymic atrophy – a 
common consequence of systemic infection (8) – nor major alterations in thymic cell 
populations, as has been shown previously for M. avium (19).  
 
An immune response develops in the thymus following mycobacterial 
infection. 
The stabilization of bacterial growth in the primary infected organ, spleen for M. 
avium and lung for M. tuberculosis, is associated with the establishment of an effective 
acquired immune response (40-42). To evaluate whether an immune response is 
established in the thymus, the expression of key cytokines required for immunity to 
mycobacteria were measured in whole organ homogenates of mice infected with M. avium 
(intravenously) or with M. tuberculosis (by aerosol), and compared to uninfected controls. 
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The selected time-points reflect periods when: 1) the peak in the immune response is 
observed in the primary infected organs upon M. tuberculosis (lung) (43) and M. avium 
(spleen) infection (40) (4 wpi for both infections); 2) the bacterial burden in the thymus is still 
increasing (4 wpi for M. tuberculosis, 4 and 12 wpi for M. avium); 3) the bacterial burden 
plateaus in the thymus (12 wpi for M. tuberculosis, 16 wpi for M. avium); 4) bacterial growth 
in the thymus has been sustained for a long period (24 wpi) (Figure 1) (18, 19). 
During both infections, IFNγ expression is significantly increased as early as 4 wpi in 
the primary infected organ (spleen for M. avium – Figure 2A; lung for M. tuberculosis – 
Figure 2B). In the thymus, IFNγ expression is increased only at later time points consistent 
with the delayed dissemination and establishment of bacterial control (16 wpi for M. avium – 
Figure 2A; 12 wpi for M. tuberculosis – Figure 2B). The kinetics of TNF expression is similar 
to that of IFNγ in mice infected with M. tuberculosis (Figure 2B). In contrast, in mice infected 
with M. avium TNF is not upregulated in the thymus and only transiently upregulated in the 
spleen (Figure 2A). In agreement with the observed changes in gene expression, elevated 
levels of IFNγ protein are detected in the thymus 16 wpi with M. avium (Figure 2C), and both 
IFNγ and TNF protein are increased in the thymus 12 wpi with M. tuberculosis (Figure 2D). 
These data show that the thymus is the site of an ongoing immune response that involves 
the production of pro-inflammatory cytokines after infection, and the cytokine levels peak 
concordantly with the control of bacterial replication. 
 
Mycobacteria-specific T cells are detected in the thymus after infection. 
To determine whether a mycobacteria-specific T cell response accompanies the 
inflammatory changes observed in the infected thymus, IFNγ production by thymus cells 
obtained from infected mice after stimulation with defined mycobacterial antigens was 
assessed. IFNγ production was specifically induced when spleen or thymus cells from M. 
avium infected mice were stimulated with M. avium protein extract or with Ag85280-294 peptide 
[primarily recognized by CD4+ T cells (36)]. These antigens led to maximal IFNγ production 
by splenocytes at 4 wpi (Figure 3A), as previously described (40). In contrast, these antigens 
did not trigger IFNγ production by thymic cells until 16 wpi and even then elicited much lower 
amounts of IFNγ (Figure 3A). Similarly, large amounts of IFNγ were produced by lung cells 
obtained from M. tuberculosis-infected mice after stimulation with the immunodominant 
epitope ESAT61-20 [recognized by CD4+ T cells (38)] or TB10.44-11 [recognized by CD8+ T 
cells (37)] as early as 4 wpi. Although a M. tuberculosis-specific response could be detected 
in the thymus as early as 4 wpi, a more substantial response was detected 12 wpi (Figure 
3B) and, as in the case of M. avium, in quite lower amounts and associated with control of 
the infection and a plateau of the bacterial burden in the thymus (Figure 3B). 
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We also determined the frequency of TB10.44-11-specific CD8+ T cells during M. 
tuberculosis infection using Kb/TB10.44-11 tetramers, which can identify antigen-specific CD8+ 
T cells independently of their function (Figure 3C and Supplementary Figure 1). Similar to 
our other data, the frequency of antigen-specific T cells closely correlated with the 
production of IFNγ in the infected organs. Taken together, these data indicate that 
mycobacteria-specific T cells are present within the thymus following infection. Although the 
magnitude of the response differs from that observed in the dominant target organs, the 
kinetics in the thymus resembles other tissue-specific responses to mycobacterial infection. 
 
Mycobacteria-infected cells in the thymus express iNOS. 
The production of IFNγ by antigen-specific T cells is a central feature of protective 
immunity against mycobacterial infection (44, 45). Among the important antibacterial actions 
of IFNγ is upregulation of inducible nitric oxide synthase (iNOS) expression by macrophages. 
iNOS catalyzes the production of nitric oxide (NO), which has a significant role in controlling 
M. tuberculosis infection (46). Despite the fact that NO plays no role in the protective 
immunity to M. avium (47, 48), iNOS expression represents a suitable marker of 
macrophage activation in this scenario. The elevated IFNγ level in the infected primary 
organs was associated with increased iNOS expression by 4 wpi. An increase in iNOS 
expression in the thymus was only observed at later time points: 24 wpi for M. avium (Figure 
4A) and 12 wpi for M. tuberculosis (Figure 4B). These data are consistent with a protective T 
cell response in the thymus leading to iNOS induction, NO production, and control of 
bacterial replication. 
In addition to measuring iNOS gene expression, we detected iNOS protein by 
immunohistochemical staining. Although iNOS is expressed in the thymus even in the 
absence of infection (49), we detected an increase in the number of cells containing M. 
avium (Figure 4C) or M. tuberculosis (Figure 4D) and expressing iNOS throughout the 
course of infection, with most of the infected cells expressing iNOS at later time points. For 
M. avium and M. tuberculosis, most infected cells in the thymus were located in the medulla 
or corticomedullary region, although occasional bacteria were observed in the cortex.  M. 
tuberculosis-infected cells were also infrequently observed in the subcapsular zone. Thus, 
our data showing augmented iNOS expression and its colocalization with infected cells 
indicates the establishment of a bona fide protective immune response within the thymus. 
Mycobacteria-infected thymi contain cells able to transfer protection against 
infection. 
Having shown that the thymus is a site of infection where antigen-specific immune 
responses are detected, we next asked whether cells within infected thymi could confer 
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protection against subsequent infection. To that end, we transplanted M. avium-infected or 
uninfected thymic lobes from WT mice under the kidney capsule of TCRα KO mice (33), that 
lack peripheral αβ T cells (Figure 5A). 
The transplanted mice were challenged with M. avium and sacrificed at 4 or 8 wpi, at 
which time thymic engraftment was confirmed macroscopically. At both time points, the 
spleens of mice transplanted with infected or uninfected thymic lobes had similar numbers of 
CD4+ T cells, indicating that cells leaving the infected or uninfected thymus were equally 
able to reconstitute the peripheral T cell pool of the recipient TCRα KO mice (Figure 5B). 
Both groups receiving thymic transplants had lower bacterial burdens than the 
untransplanted TCRα KO mice (Figure 5C). This demonstrates that the cells emerging from 
the thymic grafts are functional and can mediate protection against microbial pathogens. 
Importantly, mice receiving infected thymic grafts were significantly more protected than 
those receiving uninfected grafts, despite similar T cell reconstitution (Figure 5C). These 
data support the hypothesis that the greater protection conferred by the infected thymic 
grafts is mediated by M. avium-specific T cells contained within the grafts, that efficiently 
confer protection against infectious challenge.  
 
Mycobacteria-specific T cells within the thymus are recirculating cells. 
After establishing that antigen-specific T cells within the infected thymus produce 
protective cytokines, induce NO production, and transfer protection, we next sought to 
determine the origin of these cells. In particular, we wished to determine whether 
differentiating T cells were primed in the thymus, or alternately, whether mature 
mycobacteria-specific T cells, primed in the periphery, traffic to the thymus. 
Our previous data demonstrated that T cells that differentiate within M. avium-
infected thymi are tolerant to the invading pathogen (19). Moreover, newly differentiated T 
cells arising from the thymus are not fully mature (50) and need additional signals within 
secondary lymphoid organs to achieve full differentiation (51, 52). Therefore, we used a 
genetic model in which GFP is expressed under the control of the RAG2 promoter (34), for 
the purpose of identifying newly differentiated T cells in the thymus. The RAG2 enzyme is 
essential for genetic recombination of B and T cell antigen receptors and is down-regulated 
afterwards. Even though RAG2 is down-regulated after T cell differentiation in the thymus, 
cells remain GFP+ for about 2 weeks (50). As such, it is highly expressed in differentiating T 
cells and its expression is a useful marker to distinguish between newly differentiated T cells 
(high to intermediate GFP expression) and mature peripheral T cells (no GFP expression).  
When RAG-GFP mice were infected with M. avium there was no difference on the 
percentage of GFP- among CD4SP cells, suggesting that there is no difference on the 
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amount of thymic recirculating T cells (Figure 6A and Supplementary Figure 1). However, 
upon infection most of the Ag85280-294-specific CD4SP cells in the thymus were GFP-, 
showing a modification in the repertoire of recirculating T cells (Figure 6A). In contrast with 
what was observed for M. avium, thymi from M. tuberculosis infected mice showed an 
increase in the percentage of GFP- within CD8SP cells, suggesting an increase in T cell 
trafficking from the periphery back to the thymus (Figure 6B). A similar increase was 
detected when analyzing mycobacteria-specific T cells (TB10.44-11-specific CD8SP T cells) 
during M. tuberculosis infection, in agreement with what was observed for antigen-specific 
cells in the thymus of M. avium infected mice (Figure 6B). In both cases, no tetramer positive 
cells were found in the thymus of control uninfected mice, which is in agreement with the 
small precursor frequency we observe for T cells reactive against these mycobacterial 
antigens in naïve mice (data not shown). In parallel, we show that the majority of TB10.44-11-
specific CD8SP T cells within the thymus of WT mice infected with M. tuberculosis are 
CD44hiCD24lo (Figure 6C), a phenotype typical of re-circulating CD8+ T cells (25, 53).  
 
T cell chemokines are increased in the thymus during infection. 
The above results indicate that antigen-specific T cells from the periphery respond to 
infection in the thymus by trafficking back to this organ. To determine whether increased 
chemokine production is associated with the recruitment of mycobacteria-specific T cells to 
the thymus, we measured the expression of chemokines that recruit Th1 cells (54), including 
CXCL9, CXCL10 and CCL4, after M. avium and M. tuberculosis infection. We found 
increased mRNA expression of all three chemokines in the primary infected organs during M. 
tuberculosis infection and at least at the initial phase of M. avium infection (Figure 7A and B). 
These chemokines were also detected in the thymus though at lower levels and at later time 
points – after 16 wpi for M. avium (Figure 7A) and 12 wpi for M. tuberculosis (Figure 7B). At 
the protein level, increased CCL4 was detected in the spleen but not in the thymus during M. 
avium infection, possibly because the expression levels were low (data not shown). During 
M. tuberculosis infection, the expression of these chemokines was strongly induced in the 
lungs of mice infected for 4 weeks, and the responses appeared maximal for all three 
chemokines by 12 wpi (Figure 7C). These chemokines were also highly expressed in the 
thymus, but their expression was not detected until 12 wpi (Figure 7C). 
The high levels of CXCL9 and CXCL10 detected in the infected thymus led us to 
investigate whether mycobacteria-specific T cells express CXCR3, the receptor for these 
chemokines (54). We found the majority of TB10.44-11-specific CD8SP T cells in M. 
tuberculosis infected thymi to express high levels of the chemokine receptor CXCR3 (Figure 
7D and E).  
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To support a role for CXCR3 in the recruitment of antigen-specific T cells to the 
infected thymus, we adoptively transferred purified splenic T cells obtained from M. 
tuberculosis infected donors into congenically marked infected recipients (Supplementary 
Figure 2). Analysis of the donor cells immediately before transfer found that 30-40% of the 
CD4+ and CD8+ T cells expressed CXCR3. 24 hrs after injection, the proportion of donor 
CD4+ and CD8+ donor T cells recruited to the thymus that expressed CXCR3 was increased 
to 65-85%. The increased CXCR3 expression was limited to the infected thymus, and was 
not observed in the spleen or the lung of recipient mice (Figure 7F and Supplementary 
Figure 2). This data suggests that CXCR3 participates in the recruitment of antigen-specific 
cells to the infected thymus. Thus, although the thymus is the key organ for T cell 
differentiation, mycobacteria-specific T cells from the periphery are recruited to the thymus 
following infection. Our data is consistent with the chemokines CXCL9 and CXCL10 playing 
an important role in the recruitment of these antigen-specific T cells from peripheral organs 
to the thymus in order to fight infection.  
 
Peripheral recirculating T cells within infected thymi efficiently confer 
protection against infection. 
To confirm that peripheral T cells recirculating to infected thymi are the ones that 
confer protection to infection, RAG-GFP mice were infected with M. avium and 20 wpi 
sacrificed and their thymi and spleens collected. Highly purified T cell populations were 
sorted accordingly to the expression of GFP and of surface markers: 1) total CD4+ T cells 
from the spleen (CD3+CD4+CD8-); 2) thymic recirculating CD4SP cells (CD3+CD4+CD8-GFP-
CD24lo); 3) thymic newly differentiated CD4SP cells (CD3+CD4+CD8-GFPint). A GFPint 
population was sorted to the detriment of the total GFP+ population as we wished to exclude 
the most immature GFPhi CD4SP cells (Figure 8A). Each cell subset was transferred to 
TCRα KO mice that had been infected the previous day with M. avium. Eight weeks later, 
the mice were analyzed (Figure 8B). 
Despite receiving the same number of cells, mice that received recirculating thymic 
CD4SP cells (GFP-) had lower numbers of CD4+ T cells than animals that received either 
newly differentiated T cells from the thymus (GFPint) or total splenic T cells (Figure 8C, left 
panel). Nevertheless, administration of recirculating thymic CD4SP cells provided 
significantly more protection from M. avium infection in the spleen and liver compared to 
animals that received newly differentiated thymic T cells (Figure 8C, middle and right panels). 
In addition, the protection provided by recirculating thymic CD4SP T cells is comparable to 
that of total splenic CD4+ T cells. Although transfer of newly differentiated T cells from the 
thymus provided partial protection against M. avium infection in comparison to TCRα KO 
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mice, this was significantly reduced compared to protection conferred by recirculating thymic 
CD4SP cells. Taken together, these results indicate that T cells recirculating from the 
periphery back into the thymus are capable of protecting mice against infection. 
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Discussion 
Our understanding of the role of T cells in resistance to microbial infection is 
generally limited to the effector or memory phases of the immune response, or their role in 
vaccine-induced immunity. Despite the key role of the thymus in generating such T cells, the 
consequences of infection of the thymus itself have been rarely studied. Our previous 
studies have shown that mycobacteria disseminate to the thymus (18, 19) and alter the 
process of T cell differentiation leading to tolerance against the invading pathogen (19). Here, 
we address whether and how the immune system is able to defend the thymus against 
infection, to preserve its structure, and its ability to generate T cells.  
Our results show that like other tissues that are the target of mycobacterial infection, 
mycobacteria-specific T cells appear in the thymus following the dissemination and 
subsequent growth of bacteria. Furthermore, the appearance of antigen-specific T cells 
roughly correlates with the host’s ability to control bacterial growth in the thymus. Antigen-
specific T cells in the thymus secrete IFNγ and stimulate antimicrobial functions of infected 
cells, as manifested by the upregulation of iNOS. Thus, T cell responses in the thymus 
resemble ones occurring in the lung or spleen although they differ in magnitude. In fact, both 
the number of antigen-specific T cells and related immune molecules detected in the thymus 
is significantly lower than found in the lung or the spleen. Although the thymic immune 
response is less pronounced, its ability to control bacterial growth seems similarly efficient 
as the one established in other peripheral organs. Additionally, our previous data shows that 
cellular infiltrates and granuloma-like lesions, characteristic of inflammation in other tissues, 
are not detected in the infected thymus (18). The reasons for this difference are not clear, 
but we speculate that avoiding a massive pro-inflammatory state and preventing disruption 
of the cellular architecture is required for the thymus to remain functional. The smaller 
magnitude of the thymic-associated immune response might contribute to the maintenance 
of thymic integrity during the course of infection. It has previously been shown that infection 
with a highly virulent M. avium strain, which is associated with a vigorous immune response, 
causes robust thymic atrophy (48). Recent results from our laboratory (55) show that this 
depends on a synergistic effect between IFNγ-induced iNOS induction and corticosteroid 
production, as blocking the effect of each one individually prevents thymic atrophy. Of notice, 
infection with the low virulence M. avium strain used in the present work is not accompanied 
by increased serum levels of corticosteroids (55), which may contribute to the maintenance 
of thymic integrity reported here. 
An important question that our data address is the origin of antigen-specific T cells in 
the thymus that mediate protection against mycobacterial infection. In our model, T cells 
from the periphery recirculate back to the thymus and are responsible for bacterial control. 
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Thus, although the thymus maintains the differentiation of T cells during infection, these do 
not appear to be the cells that defend the thymus against infection. These data are 
consistent with our previous results showing that newly differentiated T cells that mature in a 
thymus infected by M. avium are tolerant to mycobacterial antigens, and consequently are 
not optimally able to establish protective immunity(19). Interestingly, T cells that differentiate 
in an infected thymus were not completely impaired in their ability to proliferate, to traffic to 
infected organs, and to confer a small amount of protection against infection, albeit less 
efficiently than T cells that develop within an uninfected thymus (19). In agreement with 
those findings, we now report that newly differentiated T cells are much less effective at 
conferring protection than peripheral T cells that recirculate back to thymus. Therefore, we 
conclude that recirculation of peripheral activated T cells back to the thymus is a mechanism 
to survey and protect this organ from invading pathogens. 
These data are also in agreement with other work that finds newly differentiated T 
cells defective in Th1 commitment (dampened cytokine production and transcriptional factor 
expression) and biased toward the Th2 lineage (56), and a requirement for newly 
differentiated T cells to exit the thymus and reside in the periphery before they become fully 
functional (50-52). 
Another interesting question arising from this study concerns whether the antigen-
specific cells found in the thymus are primed in peripheral organs and traffic back to the 
thymus because of thymic infection, or are recirculating T cells that traffic back and are then 
primed within the infected thymus. Although we have not addressed this question directly, 
our data on the production of Th1 chemokines within the infected thymus, the expression of 
the cognate chemokine receptors by the antigen-specific T cells found within this organ, and 
the preferential recruitment of CXCR3+ cells to the infected thymus, strongly supports the 
notion that the antigen-specific T cells found in the thymus are primed in other tissues during 
infection and then traffic to the thymus in response to a chemokine gradient. 
Thymic recirculating T cells, the focus of multiple studies, have had numerous 
functions attributed to them including thymic surveillance, tolerance induction, and even 
modulation of both negative and positive selection (25-27). To our knowledge, the results 
presented here are the first evidence that recirculating T cells fight infection in the thymus, a 
function that has been previously hypothesized (25, 57, 58). The observation that 
mycobacteria-specific T cell trafficking to the thymus is associated with an increase in the 
levels of Th1-related chemokines in this organ, and the expression of specific chemokine 
receptors such as CXCR3 by the recirculating T cells, lead us to propose that the immune 
system has evolved mechanisms to recruit peripheral T cells to the thymus during infection. 
This might ensure that invading pathogens are unable to disrupt the thymus, the primary 
lymphoid organ where T cells are generated. Such mechanisms must be particularly 
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relevant for pre-natal and early childhood infections. In both scenarios, pathogen 
dissemination to the thymus could lead to the presentation of microbial antigens in a “self” 
context, and lead to the deletion of developing T cells that recognize pathogen-specific 
antigens. Exclusion of pathogen reactive T cells from the peripheral pool could have severe 
effects during childhood, when the peripheral T cell pool is still developing, but the 
consequences could persist throughout adulthood. 
Childhood infections are a great cause of morbidity and mortality, particularly in the 
developing world (59). Interestingly, HIV and M. tuberculosis, two of the most important 
pathogens in infants and young children, are both able to infect the thymus (16, 60) and 
thymic infection alters the output and selection of T cells in experimental models using these 
pathogens (9, 19). The evidence that thymic infection can compromise thymic function 
implies that the recruitment of protective immune responses to the thymus is essential to 
prevent detrimental alterations in immunological function. 
The implications of our study extend beyond childhood infection. Skepticism about 
the potential immunological consequences of thymic infection would not be surprising if one 
were to believe the dogma the adult thymus becomes immunologically useless as it ages 
and progressively loses function. However, our understanding of the role of the thymus 
during adulthood is rapidly evolving. Interestingly, the control of persistent infections has 
been suggested to benefit from the continuous recruitment of naïve T cells generated in the 
thymus (61, 62). In this case, alterations in the development of these T cells could be 
detrimental to the ongoing immune response. The integrity of the adult thymus is required for 
other aspects of ongoing immune responses such as antibody generation (63). This 
observation raises the hypothesis that thymic disruption secondary to infection can impair T 
cell responses to infection as well as other components of the immune system. Additionally, 
decreased thymic output contributes to the progression from HIV infection to AIDS (7, 64), 
indicating that thymic export is important in the context of chronic infection in adults, 
especially in the context of M. tuberculosis/HIV co-infection. Combined, these data show that 
thymic infection has an impact on the development of the immune system and ongoing 
immune responses to pathogens. Thus, it is not surprising that mechanisms have evolved to 
specifically respond to the invasion of the thymus by microbial pathogens. We propose that 
the recirculation of T cells from the periphery to the thymus, and the presence of mature T 
cells in this organ, represent strategies that evolved to protect the thymus and sustain its 
activity during and after infectious episodes. 
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Figure Legends 
Figure 1. M. tuberculosis infection of the thymus. A. Bacterial burden in the lung, spleen 
and thymus after aerosol infection with M. tuberculosis. Data is pooled from eleven 
independent experiments each with 3 to 7 subjects per time point, for a total 97 subjects. 
Each dot represents one mouse, the solid line is the mean, and the dashed line is the lower 
detection limit. Number of thymocytes (B) and percentage of the main thymocyte populations 
(based on CD3, CD4 and CD8 expression) (C) after M. tuberculosis infection. Both infected 
(closed bars) and age-matched uninfected controls (open bars) are represented. *, p<0.05 
by Mann-Whitney U test. Bars represent the mean ± SEM (n = 5 mice/group). Data is 
representative of two independent experiments.  
 
Figure 2. An immune response is established in the thymus after mycobacteria 
infection. RNA expression levels were determined by qPCR (A, B) and protein 
concentration were determined by multiplex (C, D) in tissues of M. avium (A, C) and M. 
tuberculosis (B, D) infected mice. Bars refer to fold increase of infected mice in comparison 
to the average of uninfected mice and represent mean ± SEM (n = 4 to 8 mice/group). Data 
is representative of 2 to 3 independent experiments. *, p<0.05 by Mann-Whitney U test 
(statistics were performed by comparing uninfected with infected mice, before performing the 
ratio).  
 
Figure 3. Mycobacteria-specific T cell responses are detected in the thymus after M. 
avium and M. tuberculosis infection. Cells from M. avium (A) or M. tuberculosis (B) 
infected mice were stimulated in vitro in the presence of M. avium protein extract or Ag85280-
294 peptide (A) and ESAT61-20 or TB10.44-11 peptides (B). Age-matched uninfected mice were 
used as controls. Unstimulated and Concanavalin A or αCD3/αCD28 stimulated cultures 
were used as negative and positive controls of the in vitro stimulation, respectively (data not 
shown). IFNγ quantification in cell supernatants was performed by ELISA. C. TB10.4-
specific CD8+ T cells were detected in lung and thymus of M. tuberculosis infected mice 
using the Kb/TB10.44-11 tetramer. Closed symbols represent infected mice and open symbols 
uninfected mice. Data points represent the mean ± SEM (n = 4 to 6 mice/group). Data is 
representative of two to four independent experiments. *, p<0.05 by Mann-Whitney U test. 
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Figure 4. Mycobacterial infection in the thymus is associated with increased iNOS 
expression. iNOS RNA expression levels were quantified by qPCR in tissues of M. avium 
(A) and M. tuberculosis (B) infected mice. Bars refer to fold increase of infected mice in 
comparison to the average of uninfected mice and represents the mean ± SEM (n=4 to 8 
mice/group). Data is representative of 2 to 3 independent experiments. *, p<0.05 by Mann-
Whitney U test (statistics were performed by comparing uninfected with infected mice, 
before performing the ratio). C, D. Representative medullary thymic sections of M. avium (C) 
and M. tuberculosis (D) infected thymi stained for iNOS (brown). Bacilli were detected by 
Ziehl-Neelsen staining. Shown are representative images obtained from the analysis of 3 to 
5 thymi per time-point from of 2 to 3 independent experiments. Bar = 10µm. 
 
Figure 5. M. avium-infected thymi contain T cells able to confer protection during 
infection. A. Schematic representation of the experiment. Thymic lobes from M. avium 
infected mice (24 wpi) or from uninfected WT mice were transplanted under the kidney 
capsule of TCRα KO receptor mice. Transplanted mice were infected 2 to 3 days post-
transplant and sacrificed 4 and 8 weeks later. Non-transplanted TCRα KO mice were used 
as controls. Number of CD4+ T cells (B) and bacterial load (C) were assessed in the spleen. 
Each column represents mean ± SEM (n = 4 mice/group) from one of two experiments. *, 
p<0.05 by one-way ANOVA. 
 
Figure 6. Mycobacteria-specific T cells recirculate to the thymus upon infection. A. 
Total recirculating CD4SP cells from the thymi of naïve or M. avium-infected RAG-GFP mice 
and recirculating CD4SP Ag85-specific cells from the thymi of infected mice were 
enumerated. Represented are density plots of the expression of the GFP marker in total 
CD4SP cells (left) and in CD4SP Ag85+ cells (right). B. Total recirculating CD8SP cells from 
the thymi of naïve or M. tuberculosis-infected RAG-GFP mice and recirculating CD8SP 
TB10.4-specific cells from the thymi of infected mice were enumerated. Represented are 
density plots of the expression of the GFP marker in total CD8SP cells (left) and in CD8SP 
TB10.4+ cells (right). C. In WT mice, using the surface markers CD44 and CD24, total 
recirculating CD8SP cells and recirculating CD8SP TB10.4-specific cells from the thymi of 
infected mice were enumerated. Represented are density plots of the expression of CD44 
and CD24 in total CD8SP cells (left) and in CD8SP TB10.4+ cells (right). All represented dot 
plots show concatenated data from all animals of the group. Bars represent mean ± SEM. 
Data is pooled from 2 to 3 independent experiments, with 5 to 8 mice/group. *, p<0.05 by 
one-way ANOVA. 
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Figure 7. Recirculation of mycobacteria-specific T cells into infected thymi correlates 
with increased Th1 recruiting chemokines and their cognate receptors. RNA 
expression (A, B) and protein concentration (C) were determined in tissues of M. avium (A) 
and M. tuberculosis (B, C) infected mice. Bars refer to fold increase of infected mice in 
comparison to the average of uninfected mice and represents mean ± SEM (n = 4 to 8 
mice/group). Data is representative of 2 to 3 independent experiments. *, p<0.05 by Mann-
Whitney U test (statistics were performed by comparing uninfected with infected mice, 
before performing the ratio).  D. FACS plot of CXCR3 expression in thymic CD8SP TB10.4- 
and CD8SP TB10.4+ cells from M. tuberculosis-infected mice. Represented is the 
concatenated data from 3 mice analyzed. Gating strategy is depicted in Supplementary 
figure 1. E. Percentage of CXCR3 expressing cells between CD8SP TB10.4- and CD8SP 
TB10.4+ cells in M. tuberculosis-infected mice. Each bar represents mean ± SEM (n = 4 to 8 
mice/group). Data is representative of 2 to 3 independent experiments. F. CXCR3 
expression by donor CD4SP and CD8SP in the spleen and thymus. T cells from M. 
tuberculosis-infected CD45.2 mice were transferred to M. tuberculosis-infected CD45.1 
recipient mice, and their CXCR3 expression was analyzed the next day. See Supplementary 
Figure 2 for scheme and gating strategy. Each bar represents mean ± SEM (n = 3 mice). 
Data is representative of 3 independent experiments.  *, p<0.05 by one-way ANOVA. 
 
Figure 8. Thymic recirculating T cells from M. avium-infected mice efficiently confer 
protection to infection. 20 weeks after M. avium infection, RAG-GFP mice were sacrificed 
and their thymi and spleens removed. Spleen CD4+CD3+ cells, thymic CD3+CD4+CD8-GFP-
CD24lo (recirculating) cells and thymus CD3+CD4+CD8-GFPint cells were sorted and 4 to 
4.2×105 cells (depending on the experiment) were transferred to TCRα KO mice one day 
after M. avium infection. Mice were sacrificed 8 weeks post-transfer. Non-transplanted TCRα 
KO mice were used as controls. A. Purity of the transfered thymic populations. Thymic cell 
suspensions were depleted of CD8+ cells (top panels); and CD3+CD4+CD8-GFPint (middle 
panels) and CD3+CD4+CD8-GFP-CD24lo (bottom panels) cells populations were sorted. B. 
Schematic representation of the experiment. C. Number of spleen CD4+ T cells (left panel) 
and bacterial load in the spleen (middle panel) and liver (right panel) were assessed. Each 
column represents mean ± SEM (n = 4 to 9 mice/group) from two combined independent 
experiments. *, p<0.05 by one-way ANOVA. 
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Supplemental Figure 1. Gating strategy showing the analysis of (A) M. avium or (B) M. 
tuberculosis-specific T cells located the thymus. Single cell suspensions from thymus 
were gated for by forward and side scatter and then analyzed for their expression of CD4 
and CD8.  CD3-expressing (A) CD4SP or (B) CD8SP were analyzed using Ag85280-294-
loaded I-Ab and TB10.44–11-loaded H-2 Kb tetramers. Dual tetramer staining was used to 
identify the TB10.44–11-specific CD8+ T cells in M. tuberculosis infected mice. Thymi from 
age-matched uninfected and infected mice were analyzed in parallel to assist with defining 
the positive gates.   
 
Supplemental Figure 2. Adoptive transfer of CXCR3-expressing T cells. (A) 
Experimental strategy to analyze the role of CXCR3 in the trafficking of M. tuberculosis–
specific T cells to the thymus. (B) Gating strategy for the phenotypic analysis of donor cells 
in the tissues of recipient mice. Single cell suspensions were obtained from different tissues 
and lymphocytes gated based on FSC and SSC. Donor T cells were detected by their 
expression of CD3 and CD45.2. CD4+ and CD8+ T cells were identified and their expression 
of CXCR3 was determined. All represented dot plots show concatenated data from all 
animals of the group. (C) Expression of CXCR3 by donor CD4 (top bar graph) and CD8 T 
cells (bottom bar graph).  CXCR3 expression by the donor T cells before transfer (first bar in 
each set) and after transfer in the different tissues of the M. tuberculosis infected mice. The 
donor CD4+ and CD8+ T cells found in the spleen and lung are not enriched in CXCR3 
expression compared to the transferred T cells. In contrast, the donor T cells found in the 
thymus are significantly enriched for CD4+ and CD8+ T cells that express CXCR3. Each 
column represents mean ± SEM (n = 3 independent experiments with 3-5 recipient mice per 
experiment). Lines represent differences that were statistically significant  *, p<0.05 by one-
way ANOVA. 
 
 
 
 










Part II 
CD8+ T cell responses to tuberculosis
retrogenic mice as a new mouse model to study CD8+ T cells, their protective 
capacity and their mechanism of protection
The second part of this thesis focuses on the role of CD8+ T cells 
during tuberculosis. The first chapter of this section is a review on 
our current knowledge about CD8+ T cell function following 
infection. The second chapter contains only unpublished data and 
reports our studies with a new mouse model whose T cells are 
specific for TB10, an immunodominant CD8+ T cell epitope of M. 
tuberculosis. Together, these studies start to clarify how CD8+ T 
cells modulate protective immunity against M. tuberculosis

Chapter 4 
CD8+ T cell responses to tuberculosis
Brief introduction to the role of CD8+ T cells during tuberculosis
(unpublished)
Historically, two aspects of immunity to tuberculosis have been the 
focus of attention of multiple studies: the role of CD4+ T cells in 
controlling infection; and the ability of the host to produce IFNɣ. 
While it is indisputable that both are essential components of 
successful immune responses to infection, other immunological 
features contribute to optimal immunity against tuberculosis. In this 
chapter, we review studies on the role of CD8+ T cells in infected 
people and experimental animal models of tuberculosis, and 
summarize what is known about what constitutes protective 
immunity against tuberculosis and how CD8+ T cells protect against 
M. tuberculosis infection.
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Introduction 
Tuberculosis is a major health problem and no other infectious agent is 
responsible for more deaths worldwide that M. tuberculosis1. The HIV/AIDS epidemic 
has led to the aggravation of this scenario, but has also revealed the essential role 
that adaptive immunity plays in the control of M. tuberculosis2. Therefore, there is 
great interest in clarifying which T cell subsets mediate immunity during tuberculosis, 
what are the protective mechanisms responsible for M. tuberculosis control, and 
whether vaccination can induce such mechanisms and be suitable to control infection.  
Historically, CD4+ T cells have been the focus when studying adaptive 
immune responses to tuberculosis, and there is no question concerning their 
essential role in controling infection and preventing recrudescence, in both humans 
and experimental animal models3. However, CD8+ T cells are also elicited following 
infection, are recruited to the lung, participate in granuloma formation, and are 
essential for optimal immunity against M. tuberculosis4. Interestingly, how CD8+ T 
cells contribute to protection, whether they have any unique effector function, or 
whether they are a suitable target for vaccination are all unanswered questions that 
require further investigation. 
 
CD8+ T cells are required for optimal immunity against M. tuberculosis 
Despite all the open questions about the role of CD8+ T cells during M. 
tuberculosis infection, it is now clear that they are an important component of 
functional immune responses to tuberculosis. The first real confirmation that these 
cells are required in the response to tuberculosis came from the observation, made 
by Flynn et al., that β2-microglobulin (β2m) knockout mice are extremely susceptible 
to intravenous (IV) infection with M. tuberculosis5. Because β2m is essential for the 
assembly and trafficking of the class I heavy chain, these mice do not express MHC-I. 
As a consequence of the lack of MHC-I expression in the thymus, which is essential 
for thymic selection, these mice lack CD8+ T cells. These results were confirmed by 
studies in mice lacking the expression of transporter associated with antigen-
processing (TAP)-1-/-, CD8α-/- mice and KbDb (class I MHC heavy chain)-/- mice, all of 
which have impaired resistance to M. tuberculosis infection6-11. 
These studies using knockout mice substantiate a role for CD8+ T cells during 
tuberculosis, and have been confirmed by other experimental approaches, such as 
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antibody-mediated depletion and adoptive cell transfers. For example, CD8+ T cell 
depletion has been shown to impair bacterial control following IV infection with M. 
tuberculosis virulent strain H37Rv and also BCG12. In a different study, the 
susceptibility of mice after CD8+ T cell depletion was very comparable to genetic 
ablation of MHC-I. Interestingly, CD8+ T cell depletion accentuated the effects of 
CD4+ T cell depletion following aerosol infection of mice13. The protective capacity of 
CD8+ T cells has also been confirmed by adoptive transfer of either naïve or immune 
CD8+ T cells into infected recipients. Ian Orme’s group showed that CD8+ T cells 
purified from the spleens of IV infected mice were protective when transferred to M. 
tuberculosis-infected sublethally irradiated mice14. Tascon et al. showed that naïve 
CD8+ T cells protect athymic recipients after intraperitoneal (IP) infection with M. 
tuberculosis15. Interestingly, in this study the protective capacity of CD8+ T cells was 
comparable to that of CD4+ T cells, although mice were only analyzed at 3 weeks 
post-infection. In the study of Ian Orme’s group, CD8+ T cells significantly protected 
mice upon high-dose aerosol challenge, but CD4+ T cells were significantly better at 
transferring protection during both IV and low-dose aerosol infections14. Studies from 
our own lab have confirmed that adoptive transfer of effector CD8+ T cells from 
infected mice into sub-lethally irradiated recipients confers protection against 
subsequent aerosol challenge with virulent M. tuberculosis16, and this model has 
been used to address the protective mechanisms responsible for CD8+ T cell 
protection (described below). 
Whether CD8+ T cells are important in the response against M. tuberculosis in 
humans is less well defined, but several observations support the notion that CD8+ T 
cells have a protective role following infection. For example, CD8+ T cells have been 
described as a component of granulomas17, and CD8+ T cell clones have been 
generated from the pleural fluid of tuberculosis patients but also from BCG-
vaccinated individuals as well as patients with latent infection18-23. In addition, several 
of these T cell clones have been shown to be able to recognize, and more 
importantly, kill infected macrophages23,24. Finally, several studies have focus on the 
characterization of M. tuberculosis-specific epitopes recognized by CD8+ T cells, 
expanding the arsenal of research tools available to track antigen-specific T cells 
following infection. These reagents will make possible future studies on the function 
of CD8+ T cells and their importance both during natural immunity to tuberculosis as 
well as during vaccination studies.       
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CD4+ T cells versus CD8+ T cells – historical bias? 
It is undisputable that MHC-II restricted CD4+ T cells are critical for host 
resistance against M. tuberculosis infection, in both humans and experimental animal 
models. However, one can argue against the notion that MHC-I restricted CD8+ T 
cells are less important during infection. This perception is founded on the 
observation that mice lacking CD4+ T cells (either genetically or following antibody-
mediated depletion) are more susceptible to tuberculosis than mice lacking CD8+ T 
cells13. However, it is now known that CD4+ T cell help is required for optimal CD8+ T 
cell effector function and memory generation25. Therefore, it is possible that CD4+ T 
cells are important per se, but also as modulators of CD8+ T cell activity. To support 
this idea, mice treated with depleting antibodies against CD4+ and CD8+ T cells are 
more susceptible than mice depleted of CD4+ T cells alone, suggesting that CD8+ T 
cells play a non-redundant role even during the initial stages of immune responses13. 
Also, the absence of CD4+ T cells has been shown to impair the generation of 
cytotoxicity of CD8+ T cells during tuberculosis26. Furthermore, CD4+ and CD8+ T 
cells might be necessary at different stages of infection, with CD4+ T cells being 
important during the acute phase and CD8+ T cells controlling infection during latency. 
This scenario is supported by experimental data on a model of antibiotics-induced 
latency. In this model, mice are treated with antibiotics to control disease progression, 
but when treatment is stopped disease reactivation occurs. Interestingly, treatment 
with anti-CD4 exacerbated disease, but only during the acute phase, and not during 
the latent phase. The reverse was true for anti-CD8 treatment, which did not 
influence disease severity during the acute phase, but exacerbated it during the 
latent stage12. 
Finally, CD4+ T cells and CD8+ T cells might have distinct and complementary 
functions during the course of infection. For example, CD8+ T cells are unique in their 
ability to directly kill infected cells through the production of cytotoxic molecules, such 
as granzymes and perforin in mice, and also granulysin in humans, or by the TNF or 
Fas / Fas ligand (FasL) pathways27. CD8+ T cells are theoretically capable to detect 
every infected cell, as almost every nucleated cell in the body expresses MHC-I, and 
have been shown to preferentially recognize heavily infected cells28. In contrast, 
CD4+ T cell activitation is restricted to APCs expressing MHC-II, and M. tuberculosis 
has been shown to modulate MHC-II expression following infection, which could turn 
these cells “invisible” to host CD4+ T cell surveillance29. Therefore it is possible that 
CD4+ T cells and CD8+ T cells have non-redundant, co-operative roles following 
infection, and that these change overtime as disease progresses.      
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M. tuberculosis antigens recognized by CD8+ T cells 
The idea that CD4+ T cells are more important than CD8+ T cells during M. 
tuberculosis infection has been reinforced by the elucidation of the mechanisms 
governing antigen presentation to these distinct cell types. CD4+ T cells recognize 
mostly exogenous antigens derived from proteins that are taken up by professional 
APCs by phagocytosis, degraded into peptides within specialized endocytic 
compartments, and loaded into MHC-II. On the other hand, CD8+ T cells recognize 
mostly antigens derived from proteins present in the cytosol, that are degraded by 
proteasomes, and loaded into MHC-I. Because M. tuberculosis resides primarily in 
the phagosome of infected macrophages, it is easy to envision how peptide loading 
into MHC-II and presentation to CD4+ T cells occurs. In contrast, how M. tuberculosis 
antigens end up being presented by MHC-I to CD8+ T cells has been more difficult to 
understand and has impact on antigen discovery.  
There are at least three possible mechanisms by which M. tuberculosis 
antigens end up loaded into MHC-I and presented to CD8+ T cells. These are cross-
presentation; bacterial escape to the cytosol; and antigen “leakage” to the cytosol30. 
Cross-presentation refers to the ability of APCs to transfer antigens from the 
endocytic compartment to the cytosol, where they are processed by proteasomes 
and loaded into the MHC-I pathway. Although cross-presentation has been described 
during a multitude of scenarios, the precise molecular mechanisms by which it 
occurs are mostly unclear. Interestingly, our studies have revealed a role for cross-
presentation following M. tuberculosis infection, and a connection between the cell 
death modality of the infected macrophage and the ability to generate CD8+ T cell 
responses31. We have shown that M. tuberculosis modulates the synthesis of lipid 
mediators within the infected cell, stimulating necrosis, and inhibiting apoptosis. In 
addition, infection of genetically modified macrophages that are prone to die by 
apoptosis leads to an earlier generation of CD8+ T cell responses in a process 
dependent on the presence of DC, indicative of cross-presentation31. A second 
possibility is that M. tuberculosis, or M. tuberculosis proteins, end up in the cytosol, 
where they are subject to degradation and presentation through the MHC-I pathway. 
In support of this hypothesis, M. tuberculosis has been shown to translocate from 
phagosomes to the cytosol32. Also, M. tuberculosis has been shown do disrupt host 
cell membranes, which is likely to include phagosomal membranes33. Such damage 
could allow bacterial proteins to leak to the cytosol. Alternatively, bacterial secretion 
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systems could be responsible for active transport of M. tuberculosis proteins from the 
phagosome to the cytosol.  
Although it is still unclear how M. tuberculosis antigens end up being loaded 
on MHC-I proteins, it is undisputable that they do, and that antigen-specific CD8+ T 
cell responses are elicited upon infection. Although very few epitopes have been 
defined so far, it is clear that most antigens recognized by CD8+ T cells during 
tuberculosis are derived from M. tuberculosis secreted proteins with small molecular 
weight4. This observation is consistent with the hypothesis that these proteins cross 
the phagosome membrane and end up in the cytosol. Therefore, members of the 
ESAT6 family, the Ag85 complex, the 19-kDa, 16-kDa and 38-kDa proteins and the 
Mtb32c protein are very common immunogens, in both people and mice (these 
epitopes are reviewed in extensive detail by Woodworth et al.4). Currently, there are 
five well-characterized M. tuberculosis epitopes recognized by murine CD8+ T cells: 
TB104-11, TB1020-28, CFP1033-39, 32c309-318 and EspA150-158 (Table 1). Among these, our 
studies focus mostly on TB10.44-11. 
 
Table 1: Immunodominant M. tuberculosis antigens recognized by murine CD8+ T cells 
Antigen Epitope Sequence Restriction Gene CD8 response 
CFP10 33-39 VESTAGSL KK Rv3674 25-30% 
TB10 20-28 GYAGTLQSL KD Rv3019c 30-35% 
EspA 150-158 AYLVVKTLI KD Rv3616 8-15% 
TB10 4-11 IMYNYPAM KB Rv3019c 30-50% 
32c 309-318 GAPINSATAM DB Rv0125 6-12% 
 
 
Immunodominant CD8+ T cell responses following M. tuberculosis infection: 
TB10 as a case study 
CD8+ T cell responses against most M. tuberculosis antigens are extremely 
immunodominant, i.e., focused on relatively few of all possible epitopes. This is best 
exemplified by TB10-specific responses in B6 mice, in which the majority of the CD8+ 
T cells in the infected lung are restricted to the same H-2b epitope, IMYNYPAM. This 
linear aminoacid sequence is found in two M. tuberculosis proteins, TB10.3 and 
TB10.434-37. TB10.4 (EsxH) is a small, secreted protein encoded within the ESX3 
locus, which forms a heterodimer with its partner EsxG. TB10.3 is encoded within the 
ESX5 locus and is highly homologous to TB10.4. Because these proteins share the 
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same immunodominant epitope, from now on we will not distinguish between TB10.3 
and TB10.4, and instead will use the terminology “TB10” to refer to both proteins 
(Table 2).  
 
Table 2: Comparison of TB10 proteins 
Protein TB10.3 TB10.4 
Gene Rv3019c Rv0288 
Alt. name EsxR EsxH 
Complex EsxRS EsxGH 
Locus ESX5 ESX3 
Function Unknown Fe/Zn 
 
 
TB10-specific CD8+ T cell frequencies after low dose aerosol infection range 
from 30-50% of the CD8+ T cells in the lungs of infected B6 mice, as measured by 
using peptide-loaded H-2 tetramers16,31,38. Why infected animals respond to such a 
complex organism (M. tuberculosis has approximately 4000 genes) with large 
expansions of CD8+ T cells to a few immunodominant epitopes is unclear. Also, it is 
unclear if immunodominance is beneficial or detrimental to the host. Among the 
current debated hypothesis are that immunodominance is determined by the host 
versus being driven by the bug39. The possibility that immunodominance is host 
dependent implies that T cells capable of recognizing immunodominant epitopes are 
over represented in the naïve repertoire, and argues for a protective role for such 
epitopes. Of note, this is not the case for TB10, as we have shown that the precursor 
frequency of these immunodominant CD8+ T cells is comparable to the one of 
subdominant epitopes40. Furthermore, modulation of the precursor frequency prior to 
infection by the means of vaccination could not reverse immunodominance, 
indicating that infection, rather than the host, determines this phenomenon40. One 
way M. tuberculosis could modulate immunodominance is based on the kinetics 
(early versus late) or amount (abundant versurs rare) of antigen production. In fact, it 
has been reported that M. tuberculosis antigen-coding sequences are over-
conserved in the genome, and this has been suggested to indicate that such 
antigens could serve as decoy antigens, promoting long term bacterial persistence41. 
Interestingly, TB10 antigens have been excluded from such analysis, as they are 
among the most variable genes within the M. tuberculosis genome.  
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Although our understanding of the mechanisms governing immunodominance 
is still minimal, the identification of such epitopes has allowed the development of 
tools for the detection of CD8+ T cells in vivo and made possible the study of the 
roles of these cells during tuberculosis. 
 
Effector functions of CD8+ T cells – cytokines vs cytotoxicity 
How CD8+ T cells protect against M. tuberculosis infection is still largely 
unknown. Answering this question has also been difficult because we still do not 
understand what constitutes protective immunity against tuberculosis, even for CD4+ 
T cells. Among the existing studies, the ability to produce IFNγ and TNF are the most 
commonly measured features of T cells following infection. This is because these 
cytokines seem to act synergistically to activate infected macrophages to control 
bacterial replication. IFNγ and TNF act by inducing the production of nitrogen and 
oxygen radicals with antimicrobial capacity2. The essentiality of both IFNγ and CD4+ 
T cells in the control of tuberculosis has led to the notion that IFNγ production by 
CD4+ T cells is the single defining feature of protective immunity during M. 
tuberculosis infection. Interestingly, CD8+ T cells also produce IFNγ and TNF 
following infection, both in people and experimental animal models4,24,42. Despite 
these observations, few studies have addressed the role of IFNγ and TNF production 
by CD8+ T cells during the course of infection. Tascon et al., showed that adoptive 
transfer of naïve CD8+ T cells from WT mice, but not those from IFNγ-/- mice, protect 
athymic mice from IP infection15. These data show that IFNγ production by CD8+ T 
cells can mediate protection, even in the absence of CD4+ T cells. However, this 
study fails to address if this is true in the presence of an intact CD4+ T cell 
compartment, and whether this is the most important function of CD8+ T cells in intact 
mice. Of notice, a different study suggested that CD8+ T cells, even when capable of 
producing IFNγ, cannot substitute long-term for CD4+ T cells43. As for TNF production, 
its importance for CD8+ T cell function during M. tuberculosis infection has not been 
addressed. 
Although IFNγ is critical for host defense against M. tuberculosis, several 
recent studies have emphasized the notion that IFNγ does not correlate with 
protective immunity, and that several IFNγ-independent mechanisms can contribute 
to host defense against tuberculosis. This seems particularly relevant for CD8+ T 
cells, which have the potential to be cytotoxic. In fact, cytotoxic CD8+ T cells have 
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been described in both people and experimental animal models, and the 
mechanisms responsible for CTL activity have been experimentally 
addressed16,23,24,44. Interestingly, CD8+ T cells seem to rely on multiple mechanisms 
to kill M. tuberculosis infected targets, such as Fas and TNF mediated killing and 
granule exocytosis involving granzyme and perforin16. In addition, granulysin – a 
component of CTL granules in people, but not present in mice – has been shown to 
directly kill extracellular M. tuberculosis as well as intracellular M. tuberculosis in a 
perforin-dependent manner45. These data are supported by the observation that 
perforin-/- mice show decrease survival following aerosol M. tuberculosis infection8,10.   
The observations that CD8+ T cells can produce IFNγ, TNF, and express 
multiple mechanisms of cytotoxicity establish the idea that CD8+ T cells are 
extremely heterogeneous during M. tuberculosis infection. This notion is supported 
by the detection of distinct populations of IFNγ-producing and cytolytic CD8+ T cells 
during infection46, and our unpublished observations that only 10-15% of TB10-
specific CD8+ T cells express IFNγ. Of notice, heterogeneity in gene expression at 
the single-cell level is observed during other antigen-specific CD8+ T cell responses. 
This is the case during infection with influenza virus and Listeria monocytogenes, two 
settings in which CD8+ T cells are crucial, where only a minority of responding CD8+ 
T cells coordinately expressed both perforin and granzymes47. These data suggest 
that the lack of coordinated expression of “killer genes” can limit the number of 
competent CTL and impair host protection, a possibility that should be addressed 
during M. tuberculosis infection. In addition, CD8+ T cells are slow to upregulate 
perforin expression upon stimulation48, suggesting that competent CTL might emerge 
later during infection, rather than during primary responses. Collectively, these data 
suggest that the polarization of CD8+ T cell subsets following M. tuberculosis 
challenge could result from the emergence of two distinct populations – cytokine-
producing cells during initial responses, and CTLs during latent stages – and their 
relative protecting capacities should be experimentally addressed. 
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Figure 1: Mechanisms of protection by CD8+ T cells. CD8+ T cells can be either 
cytotoxic or produce pro-inflammatory cytokines. Production of IFNγ and TNF stimulates the 
infected macrophage to control bacterial growth, while CTL activity induces apoptotic cell 
death of the infected cell. CTL activity can occur by different mechanisms, such as through 
cytotoxic granules such as granzyme and perforin; Fas/FasL mediated killing; or TNF 
mediated cell death. 
 
 
Open questions 
Although several studies have demonstrated that CD8+ T cells are essential 
for optimal immunity to tuberculosis, different aspects of CD8+ T cell biology remain a 
mystery. One of the reasons for this is the lack of an animal model to serve as a 
source of clonotypic CD8+ T cells specific for M. tuberculosis antigens. Such a model 
would allow studies on the priming and differentiation of CD8+ T cells following M. 
tuberculosis infection, their acquisition of effector functions, and on the molecular 
mechanisms responsible for CD8+ T cell-mediated protection. These studies are 
essential to understand how CD8+ T cells protect against tuberculosis; at which stage 
of infection are they most important; whether they perform any unique effector 
function; what is the contribution of cytokine production versus cytotoxicity for CD8+ T 
cell mediated protection; and whether vaccine-elicited CD8+ T cells can confer 
protection against tuberculosis, an essential condition for rational vaccine design. We 
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believe that such a model would be an invaluable tool to understand what constitutes 
protective immunity to tuberculosis, and creating such mouse was the overarching 
goal of this section of my thesis. 
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Chapter 5 
Retrogenic mice expressing CD8+ T cells specific to the 
immunodominant M. tuberculosis antigen TB10
A new  mouse model to study CD8+ T cell responses following M. tuberculosis 
infection
(unpublished)
The generation of a successful adaptive immune response is 
essential for control of infection with M. tuberculosis. However, 
despite the central role played by T cells during tuberculosis, how 
they control infection and what constitutes protective immunity 
against M. tuberculosis is still unclear. Among these, CD8+ T cells 
are essential for optimal immunity during infection, but the 
mechanisms by which they control bacterial replication are largely 
unknown. Here, we generate a new mouse model, carrying CD8+ 
T cells specific for the immunodominant antigen TB10, and 
address how these cells mediate protective immunity during 
tuberculosis.
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Abstract 
Immunity to Mycobacterium tuberculosis infection relies on the establishment 
of a successful adaptive immune response, with T cells playing a central role in 
controlling infection. Among these, CD8+ T cell responses are detected in both 
infected people and experimental animal models of tuberculosis, and CD8+ T cells 
are required for optimal immunity against virulent M. tuberculosis. To elucidate the 
role of CD8+ T cells during tuberculosis, we developed a novel mouse model with a 
high frequency of antigen-specific CD8+ T cells that recognize the immunodominant 
antigen TB10 (EsxH; Rv0288). By combining single cell sorting of tetramer positive 
cells and PCR amplification of T cell receptors (TCR), we identified and cloned four 
distinct TCRs specific for TB10.44-11. These four individual TCRs were expressed in 
mice, using retrovirus-mediated stem cell gene transfer. The resulting retrogenic (Rg) 
mice (“retro” from retrovirus, “genic” from transgenic) have a high frequency of T cells 
that express the recombinant TCR. We show that these T cells recognize and 
respond to TB10, and are able to mount protective immune responses against M. 
tuberculosis. To investigate the mechanism(s) leading to bacterial control by the 
protective clones, we generated Rg mice whose cells are unable to secrete IFNγ 
(IFNγ-/- Rgs) or incapable of perforin-mediated killing (Prf-/- Rgs). After adoptive 
transfer into irradiated recipients, we find that CD8+ Rg T cell mediated protection 
requires IFNγ, but does not require perforin. We believe this new Rg mouse model, 
the first expressing CD8+ T cells specific for an M. tuberculosis epitope, will be useful 
for defining the role of CD8+ T cells during infection and the mechanism(s) underlying 
their protective capacity. 
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Introduction 
Despite the availability of multiple anti-tuberculosis drugs and the existence of 
a vaccine – BCG – the human pathogen Mycobacterium tuberculosis is still a major 
health problem, killing approximately 1.5 million people every year and infecting one 
third of the world’s population1. The continuing HIV/AIDS epidemic and the spread of 
multi-drug resistant strains has led to the perpetuation of the worldwide tuberculosis 
epidemic. Interestingly, the majority of infected individuals do not develop active 
disease, and instead remain in an asymptomatic state termed latent infection. M. 
tuberculosis control involves the establishment of a protective adaptive immune 
response, with T cells playing a key role in this process2. Consequently, there is 
great interest in determining which T cell subsets mediate anti-mycobacterial 
immunity, delineating their effector functions, and evaluating whether vaccination can 
elicit these T cell subsets and induce protective immunity.  
While CD4+ T cells are essential for immunity to tuberculosis2, CD8+ T cell 
responses are detected in both infected people and experimental animal models of 
tuberculosis, and CD8+ T cells are recruited to the infected lung and required for 
optimal immunity against virulent M. tuberculosis3. However, what constitutes 
protective immunity against tuberculosis is still largely undefined, and how CD8+ T 
cells protect against M. tuberculosis infection is still unknown. 
The most commonly documented feature of T cells following infection is their 
ability to produce pro-inflammatory cytokines – such as IFNγ and TNF. IFNγ and TNF 
induce the production of oxygen and nitrogen radicals by infected macrophages, and 
these compounds have antimicrobial activity, leading to bacterial control4,5. Indeed, 
mice that are unable to produce IFNγ are extremely susceptible to M. tuberculosis 
infection6, and people with genetic defects in the IFNγ signaling pathway are 
incredibly susceptible to mycobacterial infections7. However, despite being critical for 
host defense, several recent studies have demonstrated that IFNγ levels do not 
correlate with protective immunity against M. tuberculosis8,9, and several IFNγ-
independent mechanisms that contribute to host defense against tuberculosis have 
been described10,11. This observation seems particularly relevant for CD8+ T cells, 
which in addition to their ability to produce cytokines have the potential to mediate 
direct cell killing. In fact, cytotoxic CD8+ T cells have been described in both people 
and experimental animal models12-14 and mice lacking components of cytotoxic 
granules, such as perforin, are more susceptible to aerosol M. tuberculosis 
infection15,16.   
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Although several studies have demonstrated that CD8+ T cells are essential 
for optimal immunity to tuberculosis, how CD8+ T cells mediate protection, at which 
stage of infection are they most important and what is the contribution of cytokine 
production versus cytotoxicity for CD8+ T cell mediated protection is still unclear.  
To answer such questions, we generated a set of retrogenic (Rg) mice that 
express a high frequency of CD8+ T cells specific for the immunodominant M. 
tuberculosis antigen TB10. We show that CD8+ T cells are primed in the draining 
lymph node around d11 after infection, acquire an activated phenotype very shortly 
after priming, and are capable of protecting mice against M. tuberculosis infection. 
Furthermore, we address the contribution of cytokine production versus cytotoxicity 
for the protection conferred by CD8+ T cells and demonstrate that IFNγ, but not 
perforin, is essential for CD8+ T cell mediated protection following infection. 
 
Materials and methods 
Mice 
C57BL/6 (WT), C57BL/6-Tg(TcraTcrb)1100Mjb/J (OT-I), B6.SJL-PtprcaPepcb/BoyJ 
(CD45.1), B6.129S7-Ifngtm1Ts/J (IFNγ-/-), C57BL/6-Prf1tm1Sdz/J (Prf-/-) and B6.129S2-
Tcratm1Mom/J (TCRα-/-) mice were purchased from The Jackson Laboratory (Bar 
Harbor, ME). Limited and Vα2var mice17 were bred in our facilities. Mice were 7 to 10 
weeks old at the start of the experiments. All animal experiments were performed in 
accordance with National and European Commission guidelines for the care and 
handling of laboratory animals and were approved by the National Veterinary 
Directorate and by the local Animal Ethical Committee or by the Dana Farber Cancer 
Institute Animal Care and Use Committee (Animal Welfare Assurance no. A3023-01), 
under Public Health Service assurance of Office of Laboratory Animal Welfare 
guidelines. Mice infected with M. tuberculosis were housed in a biosafety level 3 
facility under specific pathogen-free conditions at the Animal Biohazard Containment 
Suite (Dana Farber Cancer Institute, Boston, MA). 
Experimental infection 
For each M. tuberculosis (Erdman strain) infection, a bacterial aliquot was thawed, 
sonicated twice for 10 s in a cup horn sonicator, and then diluted in 0.9% NaCl–
0.02% Tween 80. A 15 ml suspension of M. tuberculosis was loaded into a nebulizer 
(MiniHEART nebulizer; Vortran Medical Technologies) and mice were infected via 
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the aerosol route using a nose-only exposure unit (Intox Products) and received 
100–200 CFU/mouse. At different times post-infection, mice were euthanized by 
carbon dioxide inhalation or by decapitation and organs were aseptically removed, 
individually homogenized and viable bacteria were enumerated by plating 10-fold 
serial dilutions of organ homogenates onto 7H11 agar plates. Plates were incubated 
at 37ºC and bacterial colonies were counted after 21 d. For survival experiments, 
animals were euthanatized when displaying any of the following signs: marked loss 
of appetite and fluid intake or staring coat, hunched posture and subdue behaviour or 
severe weight loss over a period of more than 3 days. When indicated, “Log 
protection” refers to the difference between the log of the bacterial load in the lung of 
control mice and the log of the bacterial load in the lung of the remaining 
experimental groups. 
Flow cytometry 
Surface staining was performed with antibodies specific for mouse CD3 (145-2C11), 
CD4 (RM4-5), CD8 (53-6.7), CD44 (IM7), CD62L (MEL-14), Vα2 (B20.1), Vβ5 (MR9-
4), Vβ11 (KT-11) (from Biolegend, CA, USA, BD Pharmingen, CA, USA, or 
eBiosciences, CA, USA). The tetramers TB10.44–11-loaded H-2 Kb (PE and APC 
labeled) were obtained from the National Institutes of Health Tetramer Core Facility 
(Emory University Vaccine Center, Atlanta, GA, USA); staining with the tetramer was 
performed for 20 min on ice during the incubation with antibodies for the surface 
staining. All cells were fixed before acquisition with 2% formaldehyde in PBS for 30 
min. Cell analysis was performed on a FACS Canto or Canto II using FACS Diva 
Software (Becton Dickinson, NJ, USA). Data were analyzed using FlowJo Software 
(Tree Star, OR, USA). Single-lymphocyte events were gated by forward scatter 
versus height and side scatter for size and granularity. 
Cell preparation and in vitro stimulation and IFNγ measurement by intracellular 
cytokine staining (ICS) 
Cell suspensions from spleen and lymph nodes were prepared by gentle disruption 
of the organs through a 70 µm nylon strainer (Fisher). For lung preparations, tissue 
was digested for 1 h at 37 °C in 1 mg/mL collagenase (Sigma) prior to straining. 
Erythrocytes were lysed using a hemolytic solution (155 mM NH4Cl, 10 mM KHCO3, 
0.1 mM sodium EDTA pH 7.2) and, after washing, cells were resuspended in 
supplemented DMEM or RPMI (10% heat inactivated FCS, 10 mM HEPES, 1 mM 
sodium pyruvate, 2 mM L-glutamine, 50 mg/ml streptomycin and 50 U/ml penicillin, 
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all from Invitrogen). Cells were enumerated in 4% trypan blue on a hemocytometer. 
0.5-1x106 cells were analyzed by flow cytometry, as described above. For ICS 
stimulations, 106 cells were plated in each well of a 96-well plate and incubated in the 
presence of TB10.44-11 peptide (10 µM; New England Peptide). Incubation in the 
presence of αCD3/αCD28 (1 ug/mL; BioLegend) or in the absence of stimuli were 
used as positive and negative controls, respectively. Golgi Stop solution (BD 
Biosciences) was added to the cultures 1 h after the start of stimulation. Cells were 
collected after 5 h of culture and the percentage of cells producing IFNγ was 
determined by intracellular cytokine staining with antibodies specific for mouse IFNγ 
(XMG1.2) (Biolegend) according to the manufacturer’s instructions.  
Single-cell sorting and PCR amplification of TB10-specific TCRs 
Cell suspensions from the lungs of individual Vα2var mice infected with M. 
tuberculosis were prepared as described above. Bulk CD8+ T cells were purified from 
each suspension using the CD8+ T cell isolation kit (from Miltenyi Biotec, Germany). 
Magnetic separation was performed using an Auto-MACS separator (Miltenyi Biotec, 
Germany). CD8+ T cells were stained with antibodies specific for mouse CD3, CD8, 
and TB10.4 tetramer, as described above. Single CD8+ T cells were sorted from this 
suspension by standard fluorescence activated cell sorter (FACS) methods into 10 ul 
of 1x modified MMLV-RT buffer (2% Triton X-100 (Sigma), 0.1 mg/ml BSA (NEB), 1.5 
mM each dNTPs (Ambion), 5 mM DTT (Invitrogen), 10 U RNAse Out (Invitrogen), 30 
U MMLV-RT (Invitrogen), 50 nM each primer (see external primers on Table 1), 
under BSL3 conditions, on a FACS Aria (Becton Dickinson). Wells were covered with 
30 uL mineral oil (Sigma) and plates sealed. cDNA synthesis was performed 
immediately after sorting, for 2 h at 37º C, followed by inactivation for 20 m at 80ºC. 
1.7 uL of the resulting cDNA was used for the first nested PCR reaction. Reactions 
were performed separately for the T cell receptor α (TCRα) and TCRβ chains in 10 
uL of 1x buffer containing 1.5 mM MgCl2, 200 nM dNTPs (Invitrogen), 200 nM each 
primer (see external primers on Table 1) and 2.5 units Platinum Taq polymerase 
(Invitrogen). Fragments were amplified for 35 cycles of 20 s denaturation at 94º C, 45 
s annealing at 52º C and 1 min extension at 72º C. 2 uL of the resulting reaction was 
used in the second step of PCR amplification, in a 20uL reaction with identical 
conditions, except for the usage of the internal primer sets (Table 1) and only for 25 
cycles of amplification. The resulting products were treated in 1x Shrimp Alkalyne 
Phosphatase buffer with 1 U SAP (USB) and 1 U exonuclease I (NEB) for 1 h at 37º 
C, the reaction inactivated at 80º C for 10 m, and products sequenced by using the 
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corresponding TCRα constant (TRAC) or TCRβ constant (TRBC) internal primers 
(Table 1).  
Generation of retrogenic mice  
Retrogenic mice were generated as previously described18. The TCRα and TCRβ 
chains were cloned with a 2A peptide-linker that allows stoichiometric expression of 
both chains of the TCR by using genomic DNA extracted from purified T cells from a 
pool of naïve WT splenocytes and the primers described in Tables 2 and 3. The 2A 
peptide-linked constructs were then subcloned into the pMIG vector, as previously 
described18. Retroviral producer cell lines were generated and used for retroviral 
transduction of murine bone marrow cells as described previously18. Transduced 
bone marrow cells were injected via the tail vein into irradiated (1200 rads) recipient 
WT mice, and mice were analyzed 5–6 weeks after adoptive cell transfer. 
Adoptive transfer of retrogenic cells  
Single cell suspensions of pools of spleens and lymph nodes from retrogenic were 
prepared. Cells were stimulated for 60-72 h in the presence of IL-2 (10 U/mL), IL-12 
(10 U/mL) and TB10 peptide (10 uM). Fresh IL-2 and IL-12 were added after 24 h of 
stimulation, and fresh IL-2 was added after 48 h of stimulation. Following stimulation, 
CD8+ T cells were purified from each suspension using the CD8+ T cell isolation kit 
(from Miltenyi Biotec, Germany). Magnetic separation was performed with LS 
columns (Miltenyi Biotec, Germany). Alternatively, CD8+ T cells were stained with 
antibodies specific for mouse CD3, CD8 and Vα2, as described above, and sorted by 
standard fluorescence activated cell sorter (FACS) methods. After purification cells 
were counted and 106 cells were transferred intravenously to each recipient. 
Recipient mice (CD45.1) were sub-lethally irradiated 4-6 hours prior to injection (600 
Rads). When used as recipients, TCRα-/- mice were not irradiated. All mice were 
infected with M. tuberculosis via the aerosol route within 24 h of cell transfer. 
Statistical analysis 
All data are represented as mean + SEM. Data were verified for Gaussian 
distribution or Mann-Whitney U test were performed to compare two groups. To 
compare more than 2 groups, one-way ANOVA, followed by Bonferroni post-hoc test 
was performed. Differences with a p<0.05 were considered significant and 
represented by *. Survival analysis was determined by Kaplan–Meier test, followed 
by a logrank (Mantel–Cox) test.  
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Results 
Generation of a TB10-specific Rg mouse model 
TB10.4 (EsxH) is a small, secreted protein encoded within the ESX3 locus, 
which forms a heterodimer with its partner EsxG. Highly homologous to TB10.4, 
TB10.3 is encoded within the ESX5 locus, and both proteins contain the H2-Kb-
restricted epitope IMYNYPAM, here called TB1019-22. TB10-specific responses can 
be tracked by using loaded H2-Kb tetramers, and after low dose aerosol infection, 
30-50% of the CD8+ T cells in the lungs of infected B6 mice recognize TB10, defining 
TB10 as an immunodominant epitope14,23-26. To study CD8+ T cell responses to M. 
tuberculosis we decided to generate Rg mice specific for TB10. We wished to obtain 
TB10-specific CD8+ T cells that expressed the Vα2 TCR so that Rg cells could be 
followed in vivo by the use of TCR-specific antibodies. Therefore, we infected Limited 
and Vα2var mice17 and analyzed their ability to generate immune responses against 
M. tuberculosis. These mice carry a Vα2 minilocus, ensuring that the specific TCRs 
recognizing TB10 would be of the Vα2 family and therefore possible to stain with 
available commercial antibodies. In addition to the Vα2 minilocus, Limited mice 
express the OT-I TCRβ chain, while Vα2var mice can pair their transgenic TCRα 
chain with any endogenous TCRβ chains17. 
Interestingly, we found that Limited mice were as susceptible to M. 
tuberculosis infection as mice without any T cells (TCRα-/-), while Vα2var mice were 
not significantly more susceptible than WT mice, despite having a reduced repertoire 
of T cells (Figure 1A). More importantly, CD8+ T cells from Vα2var mice were 
capable of recognizing TB10, based on staining with specific tetramers and 
responded to stimulation with the cognate peptide by producing IFNγ (Figure 1B and 
1C). 
Since Vα2var mice are capable of recognizing TB10, we used CD8+ T cells 
from these mice to identify TCRs specific for TB10. To do so, we sorted single cells 
from three infected mice and amplified and sequenced their TCRs. Strikingly, the 
TB10-specific repertoire was dominated by a small number of TCR sequences per 
individual mouse analyzed – 1 sequence for mouse 1 and 3, and 2 sequences for 
mouse 2 (Figure 1D). Interestingly, the complementarity determining region 3 
(CDR3) of the TCRα chains of the 4 dominant clones was diverse, both in terms of 
length and amino acid composition, but the CDR3 of the TCRβ chains was very 
conserved (Figure 1E).  
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These 4 candidate TCR sequences were amplified, linked with 2A peptides, 
used to generate retrovirus-producing cells, and transfected into bone marrow stem 
cells, leading to the generation of 4 independent retrogenic mice. The resulting mice 
express a high frequency of CD8+ T cells that express GFP (present in the vector) 
and the desired TCR (Figure 2A), and are recognized by TB10-specific tetramers 
(Figure 2B). Interestingly, the different Rg mice recognize TB10 with different 
affinities/avidities, as measured by tetramer titration on activated cells (Figure 2C). 
Despite the differences in tetramer binding, all retrogenic cells are capable of 
detecting TB10, as indicated by IFNγ production after in vitro stimulation with the 
TB10 peptide (Figure 2D). These data show that Rg cells are specific for, and 
capable of recognizing the TB10 epitope. 
 
TB10-specific CD8+ T cells are primed between d12 and d14 after infection 
To study whether Rg cells are activated in vivo, we transferred naïve purified 
CD8+ T cells from Rg TCR3 mice into congenically marked infected recipients, and 
analyzed the presence and activation status of the transferred cells in the draining 
pulmonary lymph node (pLN) and the lung at different times after aerosol infection. 
Our data shows that TB10-specific cells become activated between d12 and d14 
after infection, as measured by the upregulation of CD44 and the downregulation of 
CD62L in the retrogenic cells (Figure 3A). These cells acquire the ability to produce 
IFNγ very rapidly following activation in the pLN, with around 30% of the Rg cells 
being IFNγ+ at day 13 after infection (Figure 3B). Interestingly, Rg cells appear in the 
lung around d13 post infection, but only a small fraction expresses IFNγ upon 
stimulation at that time (Figures 3A and B). Collectively, these data show that Rg 
cells are primed in vivo following infection, and are capable of migrating to the 
infected lung.  
 
TB10-specific CD8+ T cells protect mice from aerosol infection with M. 
tuberculosis 
After establishing that TB10-specific cells are primed in vivo and traffic to the 
lung, we sought to determine if these CD8+ T cells are capable of protecting mice 
from aerosol challenge with M. tuberculosis. To address this question, Rg cells were 
differentiated in vitro with IL-2, IL-12 and TB10 peptide into an activated phenotype 
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(equivalent to a CD4+ T cell Th1 phenotype, and therefore referred to as a Tc1 
phenotype). 106 Tc1 cells were transferred into sublethally irradiated mice, and cell 
numbers and bacterial loads determined at day 21, a time point before the 
recruitment of an endogenous T cell response14. Of note, all mice had large numbers 
of Rg cells within the infected lung (Figure 4A), but some Rg cells were able to confer 
protection, while others did not provide significant protection when compared to 
activated CD8+ T cells recognizing an irrelevant peptide – OT-I cells recognize the 
ovalbumine peptide SIINFEKL, not present in M. tuberculosis (Figure 4B). Because 
even transfer of large numbers of activated OT-I cells protected mice from M. 
tuberculosis infection, we next determined how cell number correlated with protection 
in our adaptive transfer model, by using one of the most protective Rg TCRs, TCR3. 
Interestingly, transfer of as low as 104 Rg cells was sufficient to reduce bacterial 
loads in the lung of infected animals, while this effect was lost when using non-
specific OT-I cells (Figure 4C). These data show that TB10-specific CD8+ T cells are 
activated in vivo following infection, and are capable of reducing bacterial loads in the 
lung of infected mice. In addition, these results suggest that intrinsic TCR properties 
modulate the protective capacity of CD8+ T cells, as TB10-specific CD8+ T cells 
recognizing the same epitope display different degrees of protection in our model.  
Protection mediated by TB10-specific CD8+ T cells requires IFNγ production, 
but not perforin 
Having determined that TB10-specific Rg cells are capable of reducing 
bacterial load in the lung of M. tuberculosis infected mice, we next addressed the 
mechanism responsible for the protection observed. Because CD8+ T cells have 
been shown to both produce cytokines and be cytotoxic following M. tuberculosis 
infection, we generated mice with genetic defects in either pathway to assess the 
relative contribution of each of those to the protection conferred by adoptive transfer 
of Rg cells. Therefore, we generated TCR3 Rg mice using BM from IFNγ-/- or Prf-/- 
mice, and used purified CD8+ T cells from those mice in our adoptive transfer model. 
Upon transfer of 106 activated cells, Prf-/- cells led to a reduction in CFU similar to 
that of WT Rg cells, while the protective capacity of IFNγ-/- cells was significantly 
reduced (Figure 5A).  
Since perforin has been shown to be essential for the protective capacity of 
CD8+ T cells in an adoptive cell transfer model similar to ours14, we addressed 
whether differentiating Rg cells into Tc1 effectors could explain why CD8+ T cell 
mediated protection was perforin-independent. To do so, naïve Rg cells were 
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transferred to infected TCRα -/- mice, and animal survival was followed. In 
accordance with our previous results, mice receiving WT or Prf-deficient Rg cells 
survived longer than animals that received no cells or IFNγ-/- Rg cells (Figure 5B). 
These results confirm that CD8+ T cells specific for a single M. tuberculosis antigen – 
TB10 – are capable of reducing bacterial loads in the lungs of infected mice, and that 
this protective capacity is determined, at least to a large extent, by their ability to 
produce IFNγ. 
 
Discussion 
Although CD8+ T cells have been considered an essential component of 
optimal immunity during tuberculosis, how they contribution to host protection against 
M. tuberculosis is still largely undefined. One of the reasons for these shortcomings 
was the lack of an animal model that, similarly to the existing CD4+ transgenics 
specific for ESAT-627,28 and Ag8529, could be used to study CD8+ T cell responses in 
infected mice. Here we present such a model, not by the means of transgenic mice, 
but by the generation of Rg mice carrying TCRs specific for the immunodominant M. 
tuberculosis antigen TB10. These mice express the desired TCRs, and recognize 
and respond to their cognate antigen. Furthermore, our data shows that TB10-
specific Rg cells are primed in vivo following infection and migrate to the lung to fight 
M. tuberculosis infection. Interestingly, CD8+ T cell priming seems to be slightly 
delayed when compared to the data generated with ESAT-6-specific CD4+ transgenic 
T cells, reported to be primed between days 10 to 12 after infection27,28. If this is true, 
it might be one of the reasons why CD4+ T cells seem to play a more important role 
in the early stages of infection, as CD8+ T cells would only get recruited to the lung 
after the arrival of CD4+ T cells. Another possibility is that the TB10 antigen is 
expressed later than ESAT-6, and this is a difference in antigen presentation rather 
than a difference between CD4+ and CD8+ T cells. Although the exact kinetics of 
expression of M. tuberculosis antigens during infection is still unclear, this hypothesis 
is in agreement with the observation that Ag85-specific transgenic CD4+ T cells are 
also primed around d12 after infection29. 
Perhaps the most important finding of our studies is that CD8+ T cells directed 
against a single epitope of M. tuberculosis are capable of significantly reducing the 
bacterial load in the lung of infected animals, even when as few as 104 cells are 
transferred into irradiated mice. To our knowledge, this is the first demonstration that 
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TB10-specific CD8+ T cells can be protective. This data is of significant relevance 
since TB10 containing vaccines are being developed for use in people30-32. 
Interestingly, our data also raises concerns about TB10 vaccination, due to 
our observations that CD8+ T cell responses specific for this antigen are (oligo)clonal, 
and that our different Rg clones display different efficiencies to protect mice from M. 
tuberculosis challenge. That infected animals should respond to such a complex 
organism (M. tuberculosis has approximately 4000 ORF) with large expansions of 
CD8+ T cells to a few immunodominant epitopes is already unexpected, but that 
within each individual mouse each TB10-specific response is dominated by one or 
two TCR clones is even more striking. One possibility is that T cell priming in the pLN 
is so efficient that only a small number of T cell clones ever gets to contact MHC-I 
molecules loaded with TB10, and those clones expand to dominate the CD8+ T cell 
response. Alternatively, active mechanisms might exist that prevent other TB10-
reactive cells from proliferating. Future competition experiments with the different Rg 
TCRs described in this study should yield interesting answers to these questions. 
However, since different TCRs to the same antigen seem to differently mediate the 
ability of CD8+ T cells to protect mice against M. tuberculosis challenge, vaccination 
strategies need to be designed with caution, in order to elicit maybe not the strongest 
T cell responses, but instead the most protective ones. 
Finally, our data also addressed what determines a protective immune 
response against M. tuberculosis infection, at least in regard to CD8+ T cells. We 
show that CD8+ T cells require IFNγ to mediate protection, while perforin seems to be 
dispensable. These data are in agreement with the essential role of IFNγ during 
tuberculosis, and with previous publications reporting IFNγ production by CD8+ T 
cells as a protective mechanism33. However, it is important to point out that studies 
similar to ours but using in vitro activated CD4+ T cells demonstrated that CD4+ T cell 
mediated protection was independent of IFNγ production11. These data suggest that 
CD8+ T cells might be a non-redundant source of IFNγ, although their contribution in 
our model might be exacerbated since CD4+ T cell activity is reduced or absent. 
Therefore, it will be important to study CD8+ T cell responses in the presence of 
protective CD4+ T cells.  
Although our data is in agreement with previous publications on the essential 
role of IFNγ in T cell mediated protection against M. tuberculosis, our data is in 
apparent disagreement with another publication in which perforin is required for CD8+ 
T cells to be protective14. One important difference between the two studies is the 
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source of the CD8+ T cells. In this study, we use Rg cells specific for a single M. 
tuberculosis epitope, and differentiate them in vitro into Tc1 effectors. Woodworth et 
al. used polyclonal CD8+ T cells purified from the spleen of infected animals. These 
cells differentiated in vivo for a long period of time, in the presence of CD4+ T cells. 
Since CD4+ T cells have been shown to be important for the development of CTL 
activity by CD8+ T cells34, this might account for the observed differences. Another 
possibility is that CTL capacity only emerges at later stages of infection, which is not 
mimicked by our short-term culture conditions. Therefore it will be important to 
understand if our Rg cells have the capacity to differentiate into CTLs, when does 
such differentiation occur, and whether it is dependent on the presence of CD4+ T 
cells. Such experiments should provide valuable insight on the generation of CTLs 
during tuberculosis and their contribution to CD8+ T cell mediated protection. 
Collectively, these findings shed light on the mechanisms of protection 
against M. tuberculosis infection mediated by CD8+ T cells. Understanding such 
mechanisms, and clarifying what constitutes protective immunity, is an essential 
component in the rational design of vaccines against tuberculosis. 
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Figures and Tables 
 
 
Figure 1: Selection of TB10-specific TCRs for the generation of retrogenic mice. 
T cells from Vα2var mice mount immune responses to M. tuberculosis, as assessed 
by bacterial load in the lungs of WT, Vα2var, Limited and TCRα-/- mice, 4 weeks after 
aerosol infection. CD8+ T cells from Vα2var mice recognize TB10, determined by the 
presence of TB10-specific tetramer+ CD8+ T cells (B) and their ability to produce IFNγ 
following stimulation (C). TB10-specific cells are (oligo)clonal, as assessed by 
analysis of single cell TCR sequences of TB10-specific CD8+ T cells from the lung on 
3 individual Vα2var mice infected with M. tuberculosis (D) and analysis of the 
respective CDR3 aminoacid sequences of the dominant TCRs (E). * p < 0.05. 
Comparison in (A) and (B) is against the TCRα-/- group, and in (C) between the non-
stimulated and the stimulated conditions. 
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Figure 2: Retrogenic mice carry CD8+ T cells that recognize and respond to 
TB10. Retrogenic mice have CD8+ T cells that specifically recognize TB10, as they 
express GFP and stain with the respective Vα and Vβ antibodies, and bind the TB10 
tetramer. CD8+GFP+ cells are colored in green, and control CD8+GFP- cells in orange 
(A). The different TCRs recognize TB10 with different affinity/avidity, as measured by 
tetramer dilution (B). Retrogenic cells are specific for TB10, and produce IFNγ upon 
stimulation with their cognate peptide (C). 
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Figure 3: Retrogenic cells are primed between days 11 and 13, and rapidly 
acquire the ability to produce IFNγ. Naïve CD8+ T cells from Rg mice were 
transferred into CD45.1 mice 1 day following aerosol infection, and their surface 
expression of CD44 and CD62L analysed in the dLN and lung between days 11 and 
16 after aerosol infection (A). At the same time points, the ability of CD8+ T cells to 
produce IFNγ was determined by intracellular cytokine staining after stimulation with 
the TB10 peptide (B).  
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Figure 4: Retrogenic cells protect mice from aerosol infection. In vitro 
differentiated Rg cells or OT-I cells were transferred to aerosol infected sub-lethally 
irradiated B6 recipients, and their protective ability determined 21 days after transfer. 
Rg cells are present in the lung at day 21 as determined by GFP expression and 
staining with Vα2 antibody in CD8+ T cells (A), and some Rg TCRs are capable of 
protecting mice, as assessed by bacterial burden in the lung at day 21 (B). Transfer 
of 104, 105 or 106 Rg cells confers protection against M. tuberculosis challenge, as 
assessed by bacterial burden in the lung at day 21 (C). 
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Figure 5: Protection mediated by retrogenic cells dependes on IFNγ production. 
In vitro differentiated Rg cells were transferred to sub-lethally irradiated B6 recipients 
(A) or naïve cells were transferred into TCRα-/- mice (B), 1 day after aerosol infection 
with M. tuberculosis. The protective capacity of OT-I, WT, IFNγ-/- and Prf-/- cells was 
determined 21 days after transfer by measuring bacterial burden in the lung at day 
21 (A) or by following survival (B).  
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Table 1: External and internal primers for single cell PCR 
INTERNAL PRIMERS FOR TCRα  CHAIN INTERNAL PRIMERS FOR TCRβ  CHAIN 
Name SEQUENCE Name SEQUENCE 
TRAV1_int TGGATGGTTTGAAGGACAGTGGGC VB1_Int CTTTGGAATGTGAGCAACATC 
TRAV2_int CAAGGATATAAGGACTATGTGG VB2_Int CTTGAAGAATTCCCAGTATCCC 
TRAV3_int CGAAGGACAAGGATTCACTG VB3_Int CTTCAGCAAATAGACATGACTG 
TRAV4_int AACAAAGGAGAATGGRAGG VB4_Int CTTATGGACAATCAGACTGCC 
TRAV5_int GCAGATCCAAGGACTCATCG VB5_Int GCAGATTCTCAGTCCAACAG 
TRAV6_int CTCAGTGCATGAGTCAGACTC VB6_Int CAGGGAAAGGATTGAGACTG 
TRAV6D-6_int TGTTCGATAYCYTGGAGAAGG VB7_Int GAATGTGGACAGGACATGAG 
TRAV7_int TGGTACAGACAGCATYCTGG VB8_Int ATGTACTGGTATCGGCAGGAC 
TRAV8_int GTTCAAATGAGMGAGAGAAG VB9_Int GCAAGAGTTGGAAAACCAGTG 
TRAV9_int TGCTCCTCAAGTACTATTCVGG VB10_Int GTAAACGAAACAGTTCCAAGGC 
TRAV10_int GCTGGAAAGGGTCTCCACTTTGTG VB11_Int CAAGAAGCAACTCTGTGGTG 
TRAV11_int GTCAAATGGGAGATACTCAGC VB12_Int CTAAATTCATCCTTCTCCACTC 
TRAV12_int GCCACTCTCCATAAGAGCAG VB13_Int CTGTTTCCTTTTGGTGTGACC 
TRAV13_int CTTTGMMYATWTCCTCCTCC VB14_Int CTAACCTCTACTGGTACTGG 
TRAV14_int CACAATCTTCTTCAATAAAAGGG VB15_Int GAAGAACCATCTGTAAGAGTGG 
TRAV15_int GCCGCTATTCTGTAGTCTTC VB16_Int GTGACCCAGTTTCTAATCACC 
TRAV16_int CAGCAAGTGGGRAAATAGTTTT VB17_Int CCTGGTCAAAGAGAAAGGAC 
TRAV17_int CCAGAGCCTCCAGTTTCTCC VB18_Int GCTGACAGTCAAGTTGTTTCG 
TRAV19_int CACACTCCTGATATCCGTAC VB19_Int CTACAAGAAACCGGGAGAAG 
TRAV20_int AGAAGGGAAGATTCGAGGTG   
TRAV21_int GTGACTCACGGTCTACAACAAAA   
    
EXTERNAL PRIMERS FOR TCRα  CHAIN EXTERNAL PRIMERS FOR TCRβ  CHAIN 
Name SEQUENCE Name SEQUENCE 
TRAV1_ext AGCAACGTGAAGGCCAAGCC VB1_Ext GGAAACAGCACTCATGAACAC 
TRAV2_ext CAAGAAGTGAACGTGTCCTG VB2_Ext CTACAGACCCCACAGTGAC 
TRAV3_ext TATCATYTGCACCTACACAGAC VB3_Ext CAAGATATCTGGTGAAAGGGC 
TRAV4_ext CTGCTCTGAGATGCAATTTTWC VB4_Ext AGTATCTAGGCCACAATGC 
TRAV5_ext TGGTATAAGCAAGAACCTGG VB5_Ext CTCYTGGGAACAAGTTCAGC 
TRAV6_ext TATCCCGGAGAAGGTCCACAGCTC VB6_Ext CACATGGTGATGGTGGCATC 
TRAV6D-6_ext GCACGTATTCAGCCACAAGCATAGG VB7_Ext GAACAGGCCTTGTGGACATG 
TRAV7_ext AGCAGAGCCCAGAATCCCTC VB8_Ext TGKGWRCAAAACACATGGAGGC 
TRAV8_ext CAGTGGTACAGACAGAAGTCAG VB9_Ext TGCAGCCACTTTTGTGGATAC 
TRAV9_ext AGCTGAGATGCAASTATTCCT VB10_Ext AATTGCTGAAGATTATGTTTAGC 
TRAV10_ext GTGTTCGAGAGGGAGACAGCGC VB11_Ext GAGAGCAGAACCAACAAATGC 
TRAV11_ext GGTGGTTCAAACAGGACAC VB12_Ext GCAAGTCTCTTATGGAAGATGG 
TRAV12_ext CTGTGATGCTGAACTGCACC VB13_Ext GTTCCTTGACACAGTACTGTC 
TRAV13_ext CAGTGGTTTTACCAAMRTCCT VB14_Ext GCTCAGACTATCCATCAATGG 
TRAV14_ext CCCAATCTCTGACAGTCTGG VB15_Ext TTCTGGGGCCTGGCTGTG 
TRAV15_ext GTGATTCAGGTCTGGTCAAC VB16_Ext GAAGCAGGACACACAGGAC 
TRAV16_ext GAAGACAACGGTGACAATGG VB17_Ext GCAGCTCTTTATGTTGCTGG 
TRAV17_ext CATACAGTGCAGCACCTTACC VB18_Ext TGTCCTCCTCTACCAAAAGC 
TRAV19_ext GATATGTTTGACTATTTTGCCTG VB19_Ext CTCTGGGGTTGTCCAGAATC 
TRAV20_ext TCACGCTCCTAATAGACATTC   
TRAV21_ext CCAGATTCAATGGAAAGTACTG   
    
CONSTANT PRIMERS FOR TCRα  AND TCRβ  CHAINS 
TRACi CGGCACATTGATTTGGGAGTC TRBCi AAGCCCCTGGCCAAGCACAC 
TRACe GGCCCCATTGCTCTTGGAATC TRBCe CTATAATTGCTCTCCTTGTAGG 
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Table 2: Primers for TCR amplification 
 NAME  Sequence (all 5’-3’) 
TCR1β        
RG1 CAACACTGAAGATGTTACTGC 
RG2 
 
GTTCCTGAGCCAAAATACAGCGTTTCTCCCCCTGTCCGTCGATCCCTAGCACCACAGAGATATAAGC 
RG3 
 
AAACGCTGTATTTTGGCTCAGGAACCAGACTGACTGTTCTCGAGGATCTGAGAAATGTGACTCCAC 
RG4 
 
CATCTTCACATCTGACTTCATG 
TCR2β        
RG5 
 
TGACCCTACTATGGATATCTGG 
RG6 AGTGCCTGGCCCAAAGTACTGGGTGTCGCCCCAGTCCCGAGCGCTGCTGGCACAGAAGTACAC 
RG7 CACCCAGTACTTTGGGCCAGGCACTCGGCTCCTCGTGTTAGAGGATCTGAGAAATGTGACTCCAC 
RG8 ATCTTCACATCTGGCTTCATG 
TCR3β        
RG9 TTCTATGAGTGAAGCCACTGC 
RG10 GTGCCCGCACCAAAGTACAAGGTGTTTTGAACCCTGTCCCTTAAGCTGCTTGCACAAAGATACACC 
RG11 ACACCTTGTACTTTGGTGCGGGCACCCGACTATCGGTGCTAGAGGATCTGAGAAATGTGACTCCAC 
RG12 ATCTTCACATCTGGCTTCATG 
TCR4β        
RG13 CCTGAGAAGAAGCATGTCTAAC 
RG14 TGCCGGGACCGAAGTACTGTTCAACCCCCCCAGGCCTGAGAGAGCTGGCACAGAAGTACATAGCAG 
RG15 GTTGAACAGTACTTCGGTCCCGGCACCAGGCTCACGGTTTTAGAGGATCTGAGAAATGTGACTCCAC 
RG16 ATCTTCACATCTGGCTTCATG 
      
TCR1α             
RG17 AGCTTCAGTCTAGGAAGAATGG 
RG18 GGTCCCTTCCCCGAATGTTAATTTACCACTTAGTCCTCCAGTATCTGCACAGAAGTAGGTAGCTGAG 
RG19 TAAATTAACATTCGGGGAAGGGACCCAAGTGACGGTAATATCTGACATCCAGAACCCAGAACCTG 
RG20 TCAGTCTTGCAGACTCAACTG 
TCR2α             
  SAME AS RG17 
RG21 CCTTCCCCGAATGTTAATTTACCACTTAGTCCTCCAGTTCCCCGACTTGCTGCACAGAAGTAGGTAGCTGAG 
RG22 GTGGTAAATTAACATTCGGGGAAGGGACCCAAGTGACGGTAATATCTGACATCCAGAACCCAGAACCTG 
  SAME AS RG20 
TCR3α             
   SAME AS RG17 
RG23 GGTCCCAGAGCCCCAGATCAGCTGATAGTTGTCACCCGTGCTGAGACAGAAGTAGGTAGCTGAGTCTCC 
RG24 TCAGCTGATCTGGGGCTCTGGGACCAAGCTAATTATAAAGCCAGACATCCAGAACCCAGAACCTG 
  SAME AS RG20 
TCR4α             
   SAME AS RG17 
RG25 GGTCCCAGAGCCCCAGATCAGCTGATAGTTGTCACCTTCCCTTGCTGCACAGAAGTAGGTAGCTGAG 
RG26 TCAGCTGATCTGGGGCTCTGGGACCAAGCTAATTATAAAGCCAGACATCCAGAACCCAGAACCTG 
  SAME AS RG20 
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Table 3: Primers for merge of TCR chains with 2A peptide 
 
MOUSE  
NAME 
Sequence (all 5’-3’) 
TCR1 
RG27 GCGCCAGAATTCAGATCTACCATGGACAAGATCCTGACAGC 
RG28 CTTCCACGTCTCCTGCTTGCTTTAACAGAGAGAAGTTCGTGGCTCCGGAGCCGGACCACAGCCTCAGC 
RG29 CTGTTAAAGCAAGCAGGAGACGTGGAAGAAAACCCCGGTCCCATGTTACTGCTTCTATTACTTCTGGG 
RG30 GCGTCGCAATTGCTCGAGTCATGAATTCTTTCTTTTGACCATAG 
TCR2 
RG31 GCGCCAGAATTCAGATCTACCATGGACAAGATCCTGACAGC 
RG32 CTTCCACGTCTCCTGCTTGCTTTAACAGAGAGAAGTTCGTGGCTCCGGAGCCGGACCACAGCCTCAGC 
RG33 CTGTTAAAGCAAGCAGGAGACGTGGAAGAAAACCCCGGTCCCATGGATATCTGGCTTCTAGGTTG 
RG34 GCGTCGCAATTGCTCGAGTCATGAATTCTTTCTTTTGACCATAG 
TCR3 
RG35 GCGCCAGAATTCAGATCTACCATGGACAAGATCCTGACAGC 
RG36 CTTCCACGTCTCCTGCTTGCTTTAACAGAGAGAAGTTCGTGGCTCCGGAGCCGGACCACAGCCTCAGC 
RG37 CTGTTAAAGCAAGCAGGAGACGTGGAAGAAAACCCCGGTCCCATGGCCCCCAGGC 
RG38 GCGTCGCAATTGCTCGAGTCATGAATTCTTTCTTTTGACCATAG 
TCR4 
RG39 GCGCCAGAATTCAGATCTACCATGGACAAGATCCTGACAGC 
RG40 CTTCCACGTCTCCTGCTTGCTTTAACAGAGAGAAGTTCGTGGCTCCGGAGCCGGACCACAGCCTCAGC 
RG41 CTGTTAAAGCAAGCAGGAGACGTGGAAGAAAACCCCGGTCCCATGTCTAACACTGTCCTCGCTG 
RG42 GCGTCGCAATTGCTCGAGTCATGAATTCTTTCTTTTGACCATAG 
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Chapter 6 
Final discussion 
An overall model for T cell responses: from the thymus to the periphery and back.
Throughout this thesis we analyzed multiple aspects of immunity 
against mycobacterial infections. These included the description of 
the thymus as a place of ongoing immunity, the characterization of 
the impact of thymic infection of T cell differentiation, but also the 
role of CD8+ T cells in peripheral immune responses. In this final 
chapter, we try to combine all these aspects into an overall model 
for T cell immunity to tuberculosis, and discuss the implications of 
our studies in the context of chronic infections, particularly in 
settings of co-infection with M. tuberculosis and HIV.
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The data presented in this thesis addresses two distinct topics related to T 
cell immunity to mycobacteria. In the first part, we focus on the role of the thymus 
during infection. In the second, on how CD8+ T cells contribute to immunity against 
Mycobacterium tuberculosis infection. We first review data on the thymus as a target 
of infection, and discuss how infection impairs thymic function. We then show how 
the thymus controls mycobacterial infections, by recruiting activated T cells from the 
periphery back to the thymus where they mount immune responses. In the second 
section, we explore immunodominance in order to generate a new mouse model to 
study when and how are CD8+ T cells important in the immune response to 
tuberculosis. In combination, the results from these projects strengthen how 
important T cells are in controlling M. tuberculosis infection, and our studies clarify 
important aspects of T cell biology following infection. Taken together, these data 
allow us to propose a slightly revised model on the involvement of T cells during 
immunity to tuberculosis. This model will serve as the basis for this discussion 
section. 
 
Figure 1. T cell responses following mycobacterial infection. Upon inhalation, 
lung macrophages uptake bacteria. Lung DC aquire bacteria and/or antigens, and transport 
them to the lymph node, where T cell priming is initiated. T cells are then recruited to the lung, 
to fight infection.  We propose that DC recirculation from the secondary lymphoid organs to 
the thymus disseminates infection to this organ. To control infection, the thymus recruits 
activated T cells from the peripheral organs, in a process dependent on production of CXCL9 
and CXCL10 by the thymus and the expression of CXCR3 by antigen-specific T cells. 
Infection of the thymus impairs thymic function and leads to alterations on the T cells 
exported from the thymus to the periphery. 
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Initiation of T cell responses 
Tuberculosis usually starts with aerosol infection of the host, and bacterial 
uptake in the lung, mostly by resident macrophages1. Although T cell activation in the 
lung following infection has been described2, most studies track initiation of adaptive 
immunity to the draining pulmonary lymph node (pLN), after M. tuberculosis antigens 
are carried to this organ by dendritic cells (DC)3,4. Our data strengthens this model, 
as we detect CD8+ T cell priming by d12 after infection in the pLN, and activated 
CD8+ T cells in the lung are only observed after this event (Chapter 5). How DC 
acquire such antigens, and how they are presented in the context of MHC-I 
molecules in order to prime CD8+ T cells is still unclear. One possibility is that M. 
tuberculosis directly infects DC, and within these cells is either able to actively 
escape to the cytosol, or that M. tuberculosis proteins leak from the phagosome to 
the cytosol. This could be the result of active secretion pathways or through rupture 
of the phagosomal membrane. In either scenario, M. tuberculosis proteins would end 
up in the cytosol, where they could be processed and presented by MHC-I. A second 
possibility is that uninfected DC acquire M. tuberculosis antigens, either soluble or 
contained within vesicles, by phagocytosis, and transfer them from this exogenous 
sampling pathway to the cytosolic MHC-I pathway. This possibility, termed cross-
presentation, as been described before, although the exact mechanisms behind it 
are still largely undefined5. The priming of CD8+ T cells by cross-presentation is 
termed cross-priming. One way DC could acquire intracellular bacterial antigens is by 
efferocytosis, i.e., the uptake of apoptotic vesicles derived from infected 
macrophages. This is the basis for the “Detour model”, in which antigens present 
within apoptotic blebs from infected macrophages are taken up by DC and cross-
presented to CD8+ T cells6,7. This model is supported by our data, reporting that 
infected macrophages die by apoptosis in vivo, and are taken up by uninfected 
macrophages, in a process of efferocytosis that contributes to bacterial control8. 
Although the ability of DC to efferocytose apoptotic macrophages was not addressed 
in this study, we have previously shown that adoptive transfer of infected 
macrophages that are genetically prone to die by apoptosis leads to an earlier CD8+ 
T cell response, in a process dependent on the present of DC9. In combination, these 
studies suggest that DC are able to engulf apoptotic vesicles derived from infected 
macrophages, process M. tuberculosis antigens, and prime CD8+ T cells.  
Another important question is why T cell priming is delayed following M. 
tuberculosis infection. Of note, M. tuberculosis infection has been reported to impair 
DC maturation10, prevent up-regulation of MHC-II11, and inhibit antigen presentation12. 
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Since DC seem to be essential for the initiation of T cell responses in the pLN, these 
observations could explain why priming is delayed. Interestingly, T cell priming – 
observed between days 11 and 12 – only seems to occur after bacterial 
dissemination to the pLN – detected around day 8 after infection3,4,13. These data 
suggest that live bacteria within DC may be necessary for the initiation of T cell 
priming. However, these results also indicate that DC could help disseminate M. 
tuberculosis infection from the lung. Another possibility is that T cell priming is 
dependent on antigenic levels within the pLN; therefore, only after bacterial 
dissemination to this organ and active replication in the pLN would priming be 
initiated. Interestingly, our data using infected macrophages that are prone to die by 
apoptosis demonstrates that initiation of T cell priming can be accelerated, even in 
the context of lower bacterial loads9, suggesting that the amount of antigen present in 
the pLN might not correlate with T cell priming efficiency. Alternatively, it is possible 
that T cell responses are geared towards bacterial antigens that are only expressed 
later during infection, and this is why T cell priming is a late phenomenon. This 
hypothesis is hard to test, since the kinetics of antigen expression by M. tuberculosis 
are still unclear, but such difference between “early” and “late” antigens could also 
explain why CD4+ T cells seem to be primed a few days earlier than CD8+ T cells – 
CD4+ T cells specific for ESAT-6 are primed between days 7 and 10 13, while CD8+ T 
cells specific for TB10 are primed between days 11 and 13 (Chapter 5). Of note, 
some M. tuberculosis proteins (like TB10) contain both CD4+ and CD8+ T cell 
epitopes, a feature that could be used to dissect between differences in the timing of 
proteins expression versus intrinsic differences between the two T cell subsets. 
Finally, it is possible that a delay in antigen processing and transfer of antigens from 
the MHC-II to the MHC-I pathway only allows CD8+ T cells to be primed after CD4+ T 
cells. This is a hypothesis that could also be tested by using different CD4+ and CD8+ 
T cell epitopes from the same bacterial proteins. 
 
The importance of immunodominance for CD8+ T cell responses 
Despite a slow start, once T cell priming is initiated, T cells expand rapidly 
and are fast to acquire effector functions, such as the ability to produce IFNγ 
(Chapter 5). Interestingly, T cell responses are incredibly focused to some M. 
tuberculosis antigens, in a process designated as immunodominance14. This is 
particularly true for CD8+ T cell responses to TB10, in which 30-50% of the cells in 
the lung at the peak of infection are direct towards a single epitope9,15,16. Furthermore, 
within each individual host, TB10-specific cells are (oligo)clonal (Chapter 5). Why 
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this happens is still unclear. There are three factors that determine the magnitude of 
antigen-specific CD8+ T cell responses: the precursor frequency of naïve T cells 
specific for a certain epitope, the capacity to recruit naïve T cells to the LN during 
priming and the subsequent expansion of the primed cells. Although we did not 
address how efficient naïve T cell recruitment is following M. tuberculosis infection, 
we have shown this process to be highly efficient during infection with other 
pathogens at multiple infectious doses17. Also, by comparing immunodominant 
responses to M. tuberculosis with subdominant responses, we have reported that 
naïve T cell precursor frequency does not correlate with the magnitude of the CD8+ T 
cell response15. Furthermore, manipulation of the precursor frequency by the means 
of vaccination was not sufficient to alter immunodominance following infection15. 
These data suggest that M. tuberculosis infection, rather than host factors, drives the 
expansion of the immunodominant T cell clones. These observations are particularly 
relevant in the context of vaccination. The assumption for vaccine design has been 
that a good vaccine will be able to boost T cell numbers prior to infection, and that 
the T cells elicited by vaccination should be protective. However, in the case of 
tuberculosis, what constitutes a protective T cell response is still unclear. Although 
the dominant view is that IFNγ is essential for the protective capacity of T cells, IFNγ 
levels do not correlate with protection conferred by vaccination18,19, i.e., IFNγ is 
necessary but not sufficient to protect the host. Also, since infection, and not the host, 
seems to determine the expansion of T cells, modulation of T cell precursor 
frequencies by vaccination may never result in protection against M. tuberculosis 
infection. Therefore, it will be important to understand what are the protective 
features of T cells and whether those can be elicited by vaccine strategies, and 
whether these can be expressed by immunodominant T cells. Finally, it is still unclear 
whether immunodominant T cell responses are beneficial for the host, or are a 
survival strategy employed by the bug to subvert immunity. Although it has been 
shown that T cell epitopes of M. tuberculosis antigens are evolutionary 
hyperconserved, suggesting that immune recognition is beneficial to the bug20, our 
observation that TB10-specific CD8+ T cells are protective during infection (Chapter 
5) argues in favor of immunodominance being beneficial for the host. This notion is 
supported by other data on protective T cell responses mediated against 
immunodominant antigens, such as ESAT-6 and Ag853,13,21. Furthermore, it is 
interesting to note that, although most M. tuberculosis antigens are hyperconserved, 
that is not the case for TB10, whose antigens display variability20. Therefore, 
although further studies are necessary to clarify this relationship, immunodominance 
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“per se” does not seem to preclude T cell protection, and therefore is probably not a 
bacterial subversion mechanism to evade adaptive immunity.   
 
Protective mechanisms of T cell-mediated immunity 
Once primed, T cells migrate to the lung, where they recognize infected cells 
and mount immune responses that lead to the control of bacterial growth. 
Interestingly, how T cells control infection is still largely unknown. Dogma is that 
production of pro-inflammatory cytokines by T cells, namely IFNγ and TNF, 
stimulates infected macrophages to produce reactive oxygen and nitrogen species 
with antibacterial potential, leading to bacteria control22,23. Our data that IFNγ 
production is essential for protection mediated by CD8+ T cells (Chapter 5) is in 
agreement with this model, although the exact mechanism(s) by which IFNγ controls 
bacterial burden in this system needs further elucidation. This data is also in 
agreement with previous studies reporting that IFNγ production by CD8+ T cells 
controls M. tuberculosis infection24. Additionally, we are now generating retrogenic 
mice lacking the ability to produce TNF in order to investigate the role of production 
of this cytokine in the protection mediated by CD8+ T cells.  However, it is now clear 
that IFNγ production by T cells does not correlate with protection, and that several 
IFNγ-independent mechanisms of M. tuberculosis control exist. This is best 
exemplified by studies using CD4+ T cells specific for ESAT-6, in which the observed 
protection mediated by these cells does not require IFNγ or TNF production25. In a 
different study, IFNγ production by CD4+ T cells did not improve bacterial control at 
early stages of infection, but was necessary for long-term control of bacterial 
replication and improved host survival26. Interestingly, IFNγ production by CD4+ T 
cells was also essential for optimal CD8+ T cell responses26, and CD4+ T cells have 
been shown to be essential for IFNγ production by CD8+ T cells27. These results 
strengthen the notion that IFNγ is necessary for optimal immunity during tuberculosis, 
but that its function might be broader than just acting to activate infected 
macrophages. This notion is strengthen by the immunoregulatory role that IFNγ plays 
during infection, such as regulating neutrophils28 or controlling IL-1β-driven immune 
pathology29. Furthermore, these studies demonstrate that other T cell functions, 
rather than IFNγ production, are essential for optimal immunity against M. 
tuberculosis infection. To address this question, we have started to perform 
microarray analysis of both CD4+ and CD8+ T cells sorted from the lung of infected 
Discussion 
	   146	  
animals at different stages of M. tuberculosis infection (data not shown). We believe 
that these data, in combination with our retrogenic mouse system, will allow us to 
identify and target new pathways that might be essential for T cell mediated control 
of bacterial replication.  
Importantly, the observations that CD4+ T cells and their production of IFNγ 
modulate CD8+ T cell function might also explain the discrepancy between the roles 
of these two T cell subsets during infection26,27,30. Historically, the observation that 
mice without CD4+ T cells are more susceptible to tuberculosis than mice lacking 
CD8+ T cells has been interpreted has proof that CD4+ T cells are essential in this 
setting, while CD8+ T cells are redundant31. However, if CD4+ T cell help is essential 
for CD8+ T cell function, an absence of CD4+ T cells would imply a defect of the 
activity of both subsets. This possibility remains to be addressed experimentally, but 
is supported by the observation that antibody depletion of both CD4+ and CD8+ T 
cells is more detrimental than depletion of CD4+ T cells alone31. How CD4+ T cells 
regulate CD8+ T cell function is also a matter of debate. One possibility is that IL-2 
production by CD4+ T cells is necessary for CD8+ T cells to acquire the ability to be 
cytolytic32. We are currently addressing this possibility, as it could explain why in our 
experimental system TB10-specific Rg cells do not require perforin for protection 
(Chapter 5), while others have reported that perforin is essential for CD8+ T cell 
mediated killing and protection in vivo16. This apparent contradiction might be 
explained by the source of the CD8+ T cells. In our study, Rg cells specific to a single 
M. tuberculosis epitope are differentiate into Tc1 effectors by short term in vitro 
culture. In contrast, Woodworth et al. used polyclonal CD8+ T cells purified from the 
spleen of infected animals16. These cells differentiated in vivo for a long period of 
time (over 5 weeks), in the presence of CD4+ T cells, which could account for the 
observed differences. Of note, IL-2 treatment of CD8+ T cells has been shown to 
upregulate the expression of perforin, but only after more than 10 days in culture33. 
This could explain why CTL capacity only emerges at later stages of infection, and 
why this is not mimicked by our short-term culture conditions. We are currently 
addressing these possibilities, namely the capacity of our Rg cells to differentiate into 
CTLs in the presence of IL-2 and/or CD4+ T cells, when does such differentiation 
occur. These experiments should provide valuable insight on the generation of CTLs 
in vivo during tuberculosis and their contribution to CD8+ T cell mediated protection. 
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Bacterial dissemination to the thymus 
Although T cells are recruited to the lung and are able to control bacterial 
replication, they fail to eradicate infection and M. tuberculosis persists in the host for 
extended periods of time34. This ability to persist may contribute to M. tuberculosis 
dissemination to other organs, a characteristic of mycobacterial infections. This is 
particularly true for lymphoid organs, and M. tuberculosis is commonly found in the 
spleen and lymph nodes. More interestingly, primary lymphoid organs are also 
infected, namely the bone marrow35 and the thymus36. Because the thymus is the 
place where T cells differentiate37, and since T cells play an essential role during 
mycobacterial infections, we investigated the role of thymic infection following 
mycobacterial challenge.  
Previous studies from our laboratory described the thymus as a target of 
mycobacterial infection, with different mycobacterial species and different infectious 
routes leading to thymic infection36. Interestingly, dissemination to the thymus occurs 
later than to other organs, but follows the same pattern as in other tissues: the initial 
bacterial burden is low, rises sharply for the first weeks after infection, and eventually 
plateaus; bacterial clearance is never achieved. How thymic infection is initiated is 
unclear, but several scenarios are possible. The first possibility is that free bacteria 
make it to the blood, enter the thymus and infect thymic cells either in a targeted or a 
random manner. Although this is possible, M. tuberculosis is a facultative intracellular 
pathogen, is mostly found within cells, and has never been reported freely in the 
blood. A more plausible explanation is that M. tuberculosis travels to the thymus 
within cells. We now appreciate that several cell types traffic between the thymus 
and the periphery. This is true for both peripheral T cells38-40, and specific DC subsets 
(such as Sirpα+ cDCs)41-43, that migrate from the periphery to the thymus, where they 
modulate thymic function. If infected, these cells could seed infection in the thymus. 
This “Trojan horse” model is supported by the observation that DC are responsible 
for disseminating M. tuberculosis from the lung to the draining lymph node3, raising 
the possibility that dissemination to the thymus can occur by a similar mechanism. 
Furthermore, we have shown that mycobacteria reside within macrophage and DC-
like cells within the thymus44. This model could also explain why thymic infection 
starts later than in other organs; M. tuberculosis dissemination to secondary 
lymphoid organs could precede DC recirculation to the thymus and delay the start of 
thymic infection. This could also be true if thymic infection is dependent on the 
dissemination of infected cells from the bone marrow to the thymus, as bone marrow 
infection is also only observed at later stages of infection35. 
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Consequences of thymic infection 
T cells differentiate in the thymus, a process dependent on thymic 
architecture, the antigens encountered by thymocytes, and the milieu surrounding 
the differentiating cells37. Because the thymus is a target of mycobacterial infection, 
and since infection can alter these features, infection can interfere with thymic 
function. In fact, our previous studies addressed how infection impacts thymic 
development. To do so, we infected mice with a M. avium strain of intermediate 
virulence that leads to chronic infection without inducing premature thymic 
atrophy44,45. Following infection, the thymus continues to support T cell differentiation, 
but the T cells that differentiate in this environment are abnormal; T cells that 
differentiate within infected thymi are suboptimally activated by M. avium antigens 
when compared to T cells that differentiate in uninfected thymi44. This defect is 
specific for M. avium antigens, as T cells from both groups respond similarly to model 
antigens44. These data indicate that infection of the thymus can induce pathogen-
specific T cell tolerance. Our observations are in agreement with studies on tolerance 
induction in viral models, such as following MLV, LCMV and HBV infection (reviewed 
in Chapter 2)46-48. It will be important to determine what is the mechanism of 
tolerance induced by thymic infection. The possibilities are the generation of 
pathogen-specific regulatory T cells, the induction of T cell anergy on the developing 
T cells or negative selection of differentiating pathogen-reactive T cells. These 
possibilities are currently being investigated, and this is an example of how the 
studies in the two sections of this thesis could be connected, as the use of retrogenic 
mice is expected to contribute to elucidate these questions. 
 
Thymic control of mycobacterial growth 
The observation that bacterial growth is halted in the thymus at later stages of 
infection suggests that an immune response is established in this organ. In fact, we 
detect antigen-specific CD4+ and CD8+ T cells within the thymus following M. avium 
and M. tuberculosis infection (Chapter 3)49. These T cells are able to produce pro-
inflammatory cytokines and activate infected cells, specifically by stimulating the 
production of inducible nitric oxide synthase (iNOS), contributing to bacterial control 
in this organ (Chapter 3)49. Importantly, we also addressed the origin of the 
responding T cells and demonstrated that these are not newly differentiated mature 
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thymocytes but instead activated peripheral T cells that recirculate back from 
peripheral organs to the thymus to fight infection (Chapter 3)49. The recruitment of 
activated T cells is associated with increased expression of T helper 1 chemokines in 
the infected thymus and an enrichment of CXCR3+ mycobacteria-specific T cells 
within this organ (Chapter 3)49. These results suggest that T cell recirculation from 
the periphery to the thymus is a mechanism that helps the immune system respond 
to thymic infection. These data are supported by other studies that also detected 
antigen-specific T cell immunity in the thymus following infection with M. 
tuberculosis50 and other pathogens. This is the case for LCMV, in which adoptively 
transferred LCMV-specific CTL traffic to the thymus and eliminate the virus from this 
organ47,51. Similarly, during influenza infection, functional influenza-specific CTLs are 
detected in thymi from HPAIV infected mice52. These results confirm that the thymus 
is not only a site of infection, but also a place of ongoing immunity, and that T cell 
recirculation from peripheral organs back to the thymus contributes to protect the 
thymus from infectious agents.  
 
Relevance of thymic infection during mycobacterial infection 
Taken together, our studies challenge the notion that the thymus is irrelevant 
during infection, as we show that the thymus is a place of infection and ongoing 
immunity, and that thymic infection has the potential to alter the peripheral T cell pool 
and impact ongoing immune responses. We believe these data to be relevant at 
least in two different scenarios. The first is in infants, when the T cell repertoire is still 
being formed. In this case, mycobacterial presence in the thymus could impact not 
only short-term immunity, but also have long lasting consequences for future immune 
response. Interestingly, BCG also disseminates to the thymus36, and this observation 
should be explored in the context of administration of live vaccines, as their presence 
and replication within the thymus could lead to tolerization of differentiating T cells.  
The impact of thymic infection during adulthood could also be of relevance. 
The argument against this is the prediction that the peripheral T cell pool should 
include pre-existing pathogen-specific T cells capable of fighting infection. However, 
in the context of persistent infection – such as tuberculosis – coupled with severe 
lymphopenia – such as during HIV – the emergence of tolerance to the infectious 
agent may impair deployment of pathogen-reactive T cells in the naïve repertoire. 
This would prevent the replenish of antigen-specific T cells in the peripheral T cell 
pool, and favor the microbe in the long-term, since it would impair T cell immunity 
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and contribute to pathogen persistence within the host. This possibility should be 
addressed experimentally in future studies focusing on TB/HIV co-infections. 
 
Future research 
The data presented and discussed in this thesis contributes to a better 
understanding of the role of T cells during mycobacterial infections. However, several 
important aspects of T cell biology remain unclear. Here I try to summarize what I 
consider the most important issues to address in future studies, with the hope that 
answering such questions will provide new insight into how T cells control M. 
tuberculosis infection and contribute in the global fight against tuberculosis.  
 
The role of the thymus during infection 
How universal is thymic infection? We show that mycobacteria 
disseminate to the thymus, and review data on the ability of multiple viruses, bacteria, 
fungi and parasites to infect the thymus, but is this a universal feature of microbes or 
specific for certain pathogens? These studies should also focus on different strains of 
the same pathogen, since strain-specific differences in the ability to infect the thymus 
could provide insight into the mechanisms of thymic infection. Also, studies on 
human populations would address the ultimate significance of these findings.  
How does the thymus get infected? The “Trojan-horse” model postulates 
that cell recirculation from the periphery to the thymus initiates thymic infection, but is 
this true for all pathogens or are there any other mechanisms that lead to infection of 
the thymus? One way this question could be addressed is by adoptive transfer of 
sorted cells infected with reporter strains of pathogens (such as fluorescent bacteria). 
Studies depleting specific cell subsets (such as the recirculating subset of DC that 
expresses Sirpα) also have the potential to be very informative. 
How does thymic infection lead to T cell tolerance? What is the 
mechanism? Does infection of the thymus lead to the development of pathogen-
specific regulatory T cells that dampen immune responses? Is the presence of 
microbial antigens within the thymus sufficient to induce negative selection of 
pathogen-specific T cells? Such studies can greatly benefit from the retrogenic 
technology described in this thesis, as bone marrow cells with the potential to 
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differentiate into mycobacterial-specific T cells can be transferred to mice with 
infected thymi, and their ability to give rise to mature T cells or Tregs can be assessed.  
 How does thymic infection during childhood affect future T cell 
immunity? The observation that thymic infection leads to the generation of 
pathogen-specific tolerance should be addressed in the context of natural infections, 
but also during vaccination.  
How does the thymus control infection? We propose a model in which 
activated T cells recirculate from the periphery back to the thymus to fight infection, 
in a CXCR3-dependent manner. Is this specific for mycobacteria, or are there other 
ways to recruit immune T cells to the thymus to fight infection? Are there any innate 
mechanisms that prevent thymic infection? These questions can be addressed with 
the same approaches that have been used in studying immunity in other organs; the 
biggest challenge here is conceptual, since the thymus should be considered an 
organ of active disease. 
The role of CD8+ T cells during infection 
What constitutes protective immunity to tuberculosis? CD4+ T cells and 
IFNγ are both necessary for a successful immune response against M. tuberculosis, 
but clearly not sufficient. What other mechanisms contribute to bacterial control? 
These studies will benefit from our gene expression profiling analysis, and the ability 
to select new targets that can be validated by the use of retrogenic mice. 
How are CD8+ T cells protective during M. tuberculosis infection? Our 
data supports that IFNγ production by these cells contributes to protection, but is this 
the only thing they do? When are CD8+ T cells important? What is more important, 
cytokines or cytotoxicity? The establishment of in vitro systems to differentiate naïve 
Rg CD8+ T cells into different phenotypes should allow adoptive transfer experiments 
similar to the ones presented in this thesis to clarify these questions. 
How do CD4+ T cells modulate CD8+ function? Is CD4+ T cell help 
necessary for the emergence of functional CTL? Is this dependent on IL-2? This 
could be addressed by a combination of in vitro strategies to differentiate CD8+ T 
cells in the presence or absence of IL-2 and adoptive transfer experiments of Rg 
cells with or without co-transfer of CD4+ T cells. 
Why are CD8+ T cell responses to M. tuberculosis immunodominant? 
Are immunodominant epitopes protective? Is immunodominance a bacterial strategy 
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to evade host immunity? Should vaccination focus on immunodominant epitopes, or 
subdominant ones? Does TCR affinity dictate immunodominance and the protective 
capacity of T cells? These studies will benefit from our establishment of different Rg 
mouse models to both immunodominant and sub-dominant epitopes, with different 
affinities to their cognate peptides. 
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